https://pharmadispatch.com/news/uncertainty-as-minister-faces-investigation 2017-01-10T01:22:01+11:00 https://pharmadispatch.com/news/pbs-headlines-ley-legacy 2017-01-16T17:07:01+11:00 https://pharmadispatch.com/news/a-new-minister-makes-change-inevitable 2017-01-16T17:06:01+11:00 https://pharmadispatch.com/news/no-1-february-listing-for-biosimilar-etanercept 2017-01-16T17:05:01+11:00 https://pharmadispatch.com/news/trump-companies-getting-away-with-murder 2017-01-16T17:04:01+11:00 https://pharmadispatch.com/news/budget-office-confirms-one-off-spike-in-pbs-spend 2017-01-17T17:03:01+11:00 https://pharmadispatch.com/news/jj-moves-closer-to-actelion-acquisition 2017-01-16T17:02:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-tga-approval-of-new-leukaemia-therapy 2017-01-16T17:01:01+11:00 https://pharmadispatch.com/news/mtpconnect-launches-final-sector-plan 2017-01-16T17:00:01+11:00 https://pharmadispatch.com/news/guild-in-pursuit-over-deloitte 2017-01-16T17:03:01+11:00 https://pharmadispatch.com/news/sussan-ley-adds-to-her-legacy-with-february-cancer-listings 2017-01-17T17:04:01+11:00 https://pharmadispatch.com/news/chewing-gum-passes-the-test 2017-01-17T17:02:01+11:00 https://pharmadispatch.com/news/pbac-looking-for-diabetes-specialist 2017-01-17T17:01:01+11:00 https://pharmadispatch.com/news/company-reappointed-to-administer-cso 2017-01-17T17:00:01+11:00 https://pharmadispatch.com/news/new-region-head-for-gsk-pharmaceuticals 2017-01-18T17:02:01+11:00 https://pharmadispatch.com/news/another-listing-for-bayers-adempas 2017-01-18T17:01:01+11:00 https://pharmadispatch.com/news/tpp-ratification-could-complicate-pharma-ip 2017-01-18T17:00:01+11:00 https://pharmadispatch.com/news/no-real-answer-for-government-senator 2017-01-18T17:03:01+11:00 https://pharmadispatch.com/news/pm-appoints-greg-hunt-to-health 2017-01-18T21:14:01+11:00 https://pharmadispatch.com/news/new-minister-same-challenge 2017-01-19T17:04:01+11:00 https://pharmadispatch.com/news/whos-ready-for-this-years-mount-kosciuszko-challenge 2017-01-19T17:01:01+11:00 https://pharmadispatch.com/news/bayer-ceo-meets-with-trump-on-monsanto 2017-01-19T17:00:01+11:00 https://pharmadispatch.com/news/sector-reminds-new-minister-of-unresolved-issues 2017-01-19T17:03:01+11:00 https://pharmadispatch.com/news/key-comments-from-greg-hunt-on-day-one 2017-01-19T17:02:01+11:00 https://pharmadispatch.com/news/major-boost-for-bi-diabetes-therapy 2017-01-20T17:03:01+11:00 https://pharmadispatch.com/news/juno-to-launch-new-speciality-antibiotic 2017-01-20T17:01:01+11:00 https://pharmadispatch.com/news/csl-upgrade-on-strong-sales 2017-01-20T17:02:01+11:00 https://pharmadispatch.com/news/uk-introduces-drug-ration-threshold 2017-01-20T17:04:01+11:00 https://pharmadispatch.com/news/servier-trio-top-leader-board 2017-01-20T17:00:01+11:00 https://pharmadispatch.com/news/australian-to-lead-gsk-pharma-globally 2017-01-20T17:05:01+11:00 https://pharmadispatch.com/news/cabinet-documents-reveal-government-considered-tenders 2017-01-23T17:03:01+11:00 https://pharmadispatch.com/news/history-makes-it-hard-to-bet-against-pharmacy 2017-01-23T17:02:01+11:00 https://pharmadispatch.com/news/offset-requirement-not-new 2017-01-23T17:01:01+11:00 https://pharmadispatch.com/news/cabinet-debated-csl-sale 2017-01-23T17:00:01+11:00 https://pharmadispatch.com/news/gilead-working-towards-epclusa-listing 2017-01-24T17:00:01+11:00 https://pharmadispatch.com/news/at-least-get-the-facts-right 2017-01-24T17:04:01+11:00 https://pharmadispatch.com/news/increase-uptake-to-promote-access 2017-01-24T17:02:01+11:00 https://pharmadispatch.com/news/mpa-welcomes-new-ministers 2017-01-24T17:03:01+11:00 https://pharmadispatch.com/news/trump-officially-withdraws-us-from-tpp 2017-01-24T17:01:01+11:00 https://pharmadispatch.com/news/turnbull-sticks-by-trade-enhancing-agreement 2017-01-25T17:04:01+11:00 https://pharmadispatch.com/news/australia-asking-for-trouble-on-ip 2017-01-25T17:03:01+11:00 https://pharmadispatch.com/news/jj-said-to-push-on-despite-actelion-study-setback 2017-01-25T17:01:01+11:00 https://pharmadispatch.com/news/mou-for-ma-and-mtpconnect 2017-01-25T17:02:01+11:00 https://pharmadispatch.com/news/jj-considering-strategic-options-for-diabetes-businesses 2017-01-25T17:00:01+11:00 https://pharmadispatch.com/news/australia-day-recognition-for-long-serving-ma-board-member 2017-01-27T17:04:01+11:00 https://pharmadispatch.com/news/medical-researcher-named-australian-of-the-year 2017-01-27T17:00:01+11:00 https://pharmadispatch.com/news/award-for-unsung-but-well-known-public-servant 2017-01-27T17:03:01+11:00 https://pharmadispatch.com/news/novartis-working-through-glivec-patent-expiry 2017-01-27T17:02:01+11:00 https://pharmadispatch.com/news/jj-acquires-actelion-for-us30bn 2017-01-27T17:01:01+11:00 https://pharmadispatch.com/news/exclusive-are-we-looking-at-pbs-reform-lite 2017-01-30T17:05:01+11:00 https://pharmadispatch.com/news/abbvie-and-bms-hit-by-high-expectations 2017-01-30T17:01:01+11:00 https://pharmadispatch.com/news/haemophilia-boosts-biogen-as-spin-off-looms 2017-01-30T17:00:01+11:00 https://pharmadispatch.com/news/political-move-for-former-ma-ceo 2017-01-30T17:03:01+11:00 https://pharmadispatch.com/news/cynical-response-to-latest-review 2017-01-30T17:04:01+11:00 https://pharmadispatch.com/news/december-pbac-outcomes 2017-01-30T17:02:01+11:00 https://pharmadispatch.com/news/wider-risk-of-ezetimibe-review 2017-01-31T17:03:01+11:00 https://pharmadispatch.com/news/greg-hunts-office-taking-shape 2017-01-31T17:01:01+11:00 https://pharmadispatch.com/news/new-cancer-listings-headline-pbs 2017-02-01T17:01:01+11:00 https://pharmadispatch.com/news/msd-report-missed-full-benefits 2017-01-31T17:02:01+11:00 https://pharmadispatch.com/news/commonwealth-responds-on-meningococcal 2017-01-31T17:00:01+11:00 https://pharmadispatch.com/news/ma-to-activate-on-possible-prescribing-change 2017-02-01T17:03:01+11:00 https://pharmadispatch.com/news/no-erc-for-greg-hunt 2017-02-01T17:02:01+11:00 https://pharmadispatch.com/news/pfizer-fourth-quarter-result 2017-02-01T17:00:01+11:00 https://pharmadispatch.com/news/sector-backs-political-process 2017-02-02T17:00:01+11:00 https://pharmadispatch.com/news/st-adopts-new-sales-model 2017-02-02T17:02:01+11:00 https://pharmadispatch.com/news/trump-targets-drug-pricing-with-trade-policy 2017-02-02T17:01:01+11:00 https://pharmadispatch.com/news/lilly-welcomes-taltz-listing 2017-02-02T17:00:01+11:00 https://pharmadispatch.com/news/new-measures-to-address-a-flagging-failure 2017-02-03T17:03:01+11:00 https://pharmadispatch.com/news/rescheduling-disappointment-for-bayer 2017-02-03T17:01:01+11:00 https://pharmadispatch.com/news/pharmac-defends-rationing-cancer-medicines 2017-02-03T17:02:01+11:00 https://pharmadispatch.com/news/az-and-msd-fourth-quarter-results 2017-02-04T05:00:01+11:00 https://pharmadispatch.com/news/amgen-jumps-on-repatha-outcomes-trial 2017-02-06T17:02:01+11:00 https://pharmadispatch.com/news/pfizer-considers-acquisitions-and-divestments 2017-02-06T17:01:01+11:00 https://pharmadispatch.com/news/ma-welcomes-labors-budget-discussion-paper 2017-02-06T17:03:01+11:00 https://pharmadispatch.com/news/a-necessary-but-risky-discussion 2017-02-06T17:05:01+11:00 https://pharmadispatch.com/news/canberra-protest-to-go-ahead 2017-02-06T17:04:01+11:00 https://pharmadispatch.com/news/more-grants-for-medical-research 2017-02-06T17:00:01+11:00 https://pharmadispatch.com/news/the-numbers-dont-lie-or-do-they 2017-02-07T17:03:01+11:00 https://pharmadispatch.com/news/tga-corrects-paper-on-herbal-regulation 2017-02-07T17:01:01+11:00 https://pharmadispatch.com/news/new-specialty-medicines-program-for-pharmacy 2017-02-07T17:00:01+11:00 https://pharmadispatch.com/news/vertex-commits-to-early-access 2017-02-07T17:02:01+11:00 https://pharmadispatch.com/news/the-billion-dollar-pbs-hole 2017-02-08T17:03:01+11:00 https://pharmadispatch.com/news/hunt-have-another-go 2017-02-08T17:04:01+11:00 https://pharmadispatch.com/news/ip-change-permanently-adopted 2017-02-08T17:01:01+11:00 https://pharmadispatch.com/news/bionomics-receives-first-milestone-payment 2017-02-08T17:02:01+11:00 https://pharmadispatch.com/news/australia-must-do-better-on-innovation 2017-02-08T17:00:01+11:00 https://pharmadispatch.com/news/gbma-sticks-with-uptake-drivers 2017-02-09T17:05:01+11:00 https://pharmadispatch.com/news/specialty-medicines-boost-for-sanofi 2017-02-09T17:04:01+11:00 https://pharmadispatch.com/news/psa-releases-new-code-of-ethics 2017-02-09T17:01:01+11:00 https://pharmadispatch.com/news/consensus-statement-of-device-registries 2017-02-09T17:00:01+11:00 https://pharmadispatch.com/news/australia-undermining-proud-tradition-of-ip-led-innovation 2017-02-09T17:02:01+11:00 https://pharmadispatch.com/news/vaccines-and-consumer-health-deliver-for-gsk 2017-02-09T17:03:01+11:00 https://pharmadispatch.com/news/abc-gets-it-wrong-on-donations 2017-02-10T17:02:01+11:00 https://pharmadispatch.com/news/pm-trims-cabinets-budget-committee 2017-02-10T17:01:01+11:00 https://pharmadispatch.com/news/department-gets-the-shts 2017-02-10T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-to-close-adelaide-biologic-facility 2017-02-10T17:03:01+11:00 https://pharmadispatch.com/news/why-taking-the-pressure-out-of-sales-helps-you-sell 2017-02-10T17:04:01+11:00 https://pharmadispatch.com/news/csl-therapy-shows-potential-in-diabetic-kidney-disease 2017-02-13T17:02:01+11:00 https://pharmadispatch.com/news/reckitt-benckiser-acquires-ex-bms-nutrition-company 2017-02-13T17:01:01+11:00 https://pharmadispatch.com/news/allergan-sets-high-expectations-for-2017 2017-02-13T17:00:01+11:00 https://pharmadispatch.com/news/has-the-abc-forgotten-what-it-did-on-statins 2017-02-13T17:05:01+11:00 https://pharmadispatch.com/news/could-there-be-a-better-way-to-guarantee-supply 2017-02-13T17:04:01+11:00 https://pharmadispatch.com/news/industry-concern-over-manufacturing-decline 2017-02-13T17:03:01+11:00 https://pharmadispatch.com/news/pharmacy-cautious-on-complementary-medicines 2017-02-14T17:01:01+11:00 https://pharmadispatch.com/news/experts-want-focus-on-teenage-immunisation 2017-02-14T17:00:01+11:00 https://pharmadispatch.com/news/trade-agreement-provides-us-a-clear-path-into-pbs-policy 2017-02-14T17:03:01+11:00 https://pharmadispatch.com/news/government-turns-to-pbs-on-health-again 2017-02-14T17:02:01+11:00 https://pharmadispatch.com/news/not-the-only-options-considered 2017-02-15T17:03:01+11:00 https://pharmadispatch.com/news/chf-wants-evidence-based-claims-for-complementary-medicines 2017-02-15T17:00:01+11:00 https://pharmadispatch.com/news/pc-risks-australian-rd-and-patient-access 2017-02-15T17:02:01+11:00 https://pharmadispatch.com/news/teva-result-boosted-by-actavis-acquisition 2017-02-15T17:01:01+11:00 https://pharmadispatch.com/news/real-or-just-rhetoric 2017-02-16T17:04:01+11:00 https://pharmadispatch.com/news/no-new-pbs-listings-in-march 2017-02-16T17:02:01+11:00 https://pharmadispatch.com/news/another-setback-in-search-for-new-alzheimers-therapy 2017-02-16T17:01:01+11:00 https://pharmadispatch.com/news/parliamentary-support-for-fight-against-prostate-cancer 2017-02-16T17:00:01+11:00 https://pharmadispatch.com/news/csl-delivers-exceptionally-strong-performance 2017-02-16T17:03:01+11:00 https://pharmadispatch.com/news/ex-ma-ceo-nominates-for-nsw-state-seat 2017-02-17T17:02:01+11:00 https://pharmadispatch.com/news/policy-options-ready-to-go 2017-02-17T17:00:01+11:00 https://pharmadispatch.com/news/doctors-want-the-ultimate-decision-on-biologic-choice 2017-02-17T17:03:01+11:00 https://pharmadispatch.com/news/experts-argue-the-benefits-of-a-new-lsdp 2017-02-17T17:01:01+11:00 https://pharmadispatch.com/news/az-boosted-by-positive-breast-cancer-trial 2017-02-20T17:03:01+11:00 https://pharmadispatch.com/news/milton-catelin-leading-what-is-now-a-very-different-organisation 2017-02-20T17:04:01+11:00 https://pharmadispatch.com/news/australia-and-nz-sign-innovation-treaty 2017-02-20T17:00:01+11:00 https://pharmadispatch.com/news/savings-measures-remain-in-the-budget 2017-02-20T17:01:01+11:00 https://pharmadispatch.com/news/industry-disagreement-over-uk-rebate-demand 2017-02-20T17:02:01+11:00 https://pharmadispatch.com/news/more-frustration-over-co-dependent-technologies 2017-02-21T17:03:01+11:00 https://pharmadispatch.com/news/focus-remains-on-supply-shortages 2017-02-21T17:02:01+11:00 https://pharmadispatch.com/news/merger-boost-for-terrywhite-chemmart-group 2017-02-21T17:00:01+11:00 https://pharmadispatch.com/news/more-australians-living-with-insulin-treated-diabetes 2017-02-21T17:01:01+11:00 https://pharmadispatch.com/news/pbac-uncertainty-as-meeting-approaches 2017-02-22T17:05:01+11:00 https://pharmadispatch.com/news/melbourne-based-company-secure-first-cannabis-licence 2017-02-22T17:00:01+11:00 https://pharmadispatch.com/news/janssen-backs-nzs-first-social-bond 2017-02-22T17:03:01+11:00 https://pharmadispatch.com/news/wa-labor-commits-to-medical-research-future-fund 2017-02-22T17:02:01+11:00 https://pharmadispatch.com/news/different-application-for-pharmac 2017-02-22T17:01:01+11:00 https://pharmadispatch.com/news/industry-pbac-nomination-progresses 2017-02-23T17:04:01+11:00 https://pharmadispatch.com/news/dramatic-sales-shift-for-blackmores 2017-02-23T17:00:01+11:00 https://pharmadispatch.com/news/hep-c-revenue-boost-for-ebos 2017-02-23T17:01:01+11:00 https://pharmadispatch.com/news/minister-will-review-unpopular-policy 2017-02-23T17:03:01+11:00 https://pharmadispatch.com/news/new-medicines-australia-board-meets 2017-02-23T17:02:01+11:00 https://pharmadispatch.com/news/industry-leaders-back-us-tax-change 2017-02-24T17:00:01+11:00 https://pharmadispatch.com/news/guild-welcomes-fair-work-commission-ruling 2017-02-24T17:01:01+11:00 https://pharmadispatch.com/news/securing-certainty-to-avoid-the-worst-reforms 2017-02-24T17:02:01+11:00 https://pharmadispatch.com/news/pharmaceuticals-dominate-bayer-result 2017-02-24T17:00:01+11:00 https://pharmadispatch.com/news/pbs-spikes-by-28-per-cent-but-its-just-not-real 2017-02-27T17:03:01+11:00 https://pharmadispatch.com/news/no-risk-deal-greatest-ever-negotiated 2017-02-27T17:02:01+11:00 https://pharmadispatch.com/news/acquisition-turbocharge-for-mayne-pharma 2017-02-27T17:01:01+11:00 https://pharmadispatch.com/news/ma-says-no-to-central-reporting-system 2017-02-27T17:04:01+11:00 https://pharmadispatch.com/news/competition-working-in-hcv-market 2017-02-27T17:00:01+11:00 https://pharmadispatch.com/news/is-it-speculation-or-semantics 2017-02-28T17:03:01+11:00 https://pharmadispatch.com/news/peter-mac-joins-bms-global-immuno-oncology-network 2017-02-28T17:02:01+11:00 https://pharmadispatch.com/news/tga-approval-for-csl-behring-lung-therapy 2017-02-28T17:01:01+11:00 https://pharmadispatch.com/news/guild-ups-pressure-on-greg-hunt 2017-02-28T17:00:01+11:00 https://pharmadispatch.com/news/ma-publishes-latest-transparency-reports 2017-03-01T17:01:01+11:00 https://pharmadispatch.com/news/ma-appoints-industry-critic-to-advisory-council 2017-03-01T17:03:01+11:00 https://pharmadispatch.com/news/parliamentary-interest-in-keytruda-for-mesothelioma 2017-03-01T17:00:01+11:00 https://pharmadispatch.com/news/a-brave-appointment 2017-03-01T17:02:01+11:00 https://pharmadispatch.com/news/lsdp-the-focus-at-senate-estimates 2017-03-02T17:04:01+11:00 https://pharmadispatch.com/news/carol-bennett-responds-to-questions 2017-03-02T17:03:01+11:00 https://pharmadispatch.com/news/promotion-for-allergans-glen-curran 2017-03-02T17:02:01+11:00 https://pharmadispatch.com/news/teams-competing-for-the-pharma-2-peak-kosi-challenge 2017-03-03T17:03:01+11:00 https://pharmadispatch.com/news/another-anti-pd-l1-cancer-therapy-emerging 2017-03-02T17:00:01+11:00 https://pharmadispatch.com/news/accc-welcomes-ma-reports 2017-03-02T17:01:01+11:00 https://pharmadispatch.com/news/chf-initially-backed-pbs-deferrals 2017-03-03T17:02:01+11:00 https://pharmadispatch.com/news/labor-to-host-health-roundtable 2017-03-03T17:01:01+11:00 https://pharmadispatch.com/news/on-the-front-foot-with-pfizer-proactive-supply 2017-03-03T17:00:01+11:00 https://pharmadispatch.com/news/sector-slams-misleading-grattan-institute-report 2017-03-06T17:00:01+11:00 https://pharmadispatch.com/news/new-grattan-report-only-proves-its-failure 2017-03-06T17:00:01+11:00 https://pharmadispatch.com/news/price-linkages-set-to-be-tested-again 2017-03-06T17:00:01+11:00 https://pharmadispatch.com/news/government-announces-nip-flu-vaccines 2017-03-06T17:00:01+11:00 https://pharmadispatch.com/news/peace-deal-for-pharmacy-guild-and-diabetes-australia 2017-03-06T17:00:01+11:00 https://pharmadispatch.com/news/timing-is-everything-when-it-comes-to-reform 2017-03-07T17:00:01+11:00 https://pharmadispatch.com/news/ma-joins-hanson-vaccination-backlash 2017-03-06T23:40:01+11:00 https://pharmadispatch.com/news/first-biosimilar-etanercept-confirmed-for-april 2017-03-07T17:00:01+11:00 https://pharmadispatch.com/news/sector-clashes-with-grattan-institute-over-report 2017-03-07T17:00:01+11:00 https://pharmadispatch.com/news/broad-skill-set-and-experience-for-ma-advisory-council 2017-03-07T17:00:01+11:00 https://pharmadispatch.com/news/new-cancer-listings-for-april 2017-03-08T17:03:01+11:00 https://pharmadispatch.com/news/rebates-ignored-as-cormann-blames-pbs-for-spike-in-government-sp 2017-03-08T17:02:01+11:00 https://pharmadispatch.com/news/new-tga-approval-for-msds-keytruda 2017-03-08T17:01:01+11:00 https://pharmadispatch.com/news/merck-moving-to-extend-cladribine-for-multiple-sclerosis 2017-03-08T17:00:01+11:00 https://pharmadispatch.com/news/hooper-current-distribution-model-unsustainable 2017-03-09T17:02:01+11:00 https://pharmadispatch.com/news/priceline-celebrates-300th-store 2017-03-09T17:01:01+11:00 https://pharmadispatch.com/news/pbac-numbers-just-meet-legal-requirement 2017-03-09T17:03:01+11:00 https://pharmadispatch.com/news/pfizer-chips-in-to-clean-up-local-community 2017-03-09T17:00:01+11:00 https://pharmadispatch.com/news/mayne-pharma-adds-another-drug-to-us-portfolio 2017-03-10T17:00:01+11:00 https://pharmadispatch.com/news/mysterious-april-price-cuts-but-massive-savings 2017-03-10T17:00:01+11:00 https://pharmadispatch.com/news/pbs-reformer-departs-public-service-today 2017-03-10T17:00:01+11:00 https://pharmadispatch.com/news/merck-adds-colour-to-mount-kosciuszko-challenge 2017-03-10T17:00:01+11:00 https://pharmadispatch.com/news/seqirus-vaccine-now-available-through-the-private-market 2017-03-10T17:00:01+11:00 https://pharmadispatch.com/news/apotex-acquires-vaccine-distribution-business 2017-03-10T09:14:01+11:00 https://pharmadispatch.com/news/greg-hunt-wins-friends-at-app 2017-03-10T17:00:01+11:00 https://pharmadispatch.com/news/alternative-facts-on-biosimilars 2017-03-10T17:00:01+11:00 https://pharmadispatch.com/news/tillack-propose-an-alternative-rather-than-just-criticise-and-co 2017-03-13T17:04:01+11:00 https://pharmadispatch.com/news/no-herceptin-for-bexsero 2017-03-13T17:03:01+11:00 https://pharmadispatch.com/news/major-party-unity-ticket-on-pharmacy 2017-03-13T17:02:01+11:00 https://pharmadispatch.com/news/government-proposes-no-jab-no-pay-no-play-policy 2017-03-13T17:01:01+11:00 https://pharmadispatch.com/news/race-for-mount-kosciuszko-enters-the-final-week 2017-03-14T17:02:01+11:00 https://pharmadispatch.com/news/what-primary-health-reform-means-for-the-sector 2017-03-14T17:04:01+11:00 https://pharmadispatch.com/news/patients-turn-to-online-peers-for-advice-and-support 2017-03-14T17:03:01+11:00 https://pharmadispatch.com/news/key-leadership-changes-for-novogen 2017-03-14T17:00:01+11:00 https://pharmadispatch.com/news/trump-announces-fda-appointment 2017-03-14T17:01:01+11:00 https://pharmadispatch.com/news/complacency-driven-by-vaccine-success 2017-03-15T17:02:01+11:00 https://pharmadispatch.com/news/research-australia-congratulates-wa-labor 2017-03-15T17:01:01+11:00 https://pharmadispatch.com/news/another-positive-trial-outcome-for-amgens-repatha 2017-03-15T17:00:01+11:00 https://pharmadispatch.com/news/us-targets-australia-over-drug-pricing 2017-03-15T17:03:01+11:00 https://pharmadispatch.com/news/this-is-why-australian-industry-should-drive-trade-negotiations 2017-03-16T17:04:01+11:00 https://pharmadispatch.com/news/gilead-extends-fellowship-reach-with-2017-grants 2017-03-17T17:03:01+11:00 https://pharmadispatch.com/news/positive-trial-result-for-azs-lynparza 2017-03-16T17:03:01+11:00 https://pharmadispatch.com/news/diabetes-companies-assess-pbac-outcome 2017-03-16T17:01:01+11:00 https://pharmadispatch.com/news/willach-pharmacy-solutions-launches-online-shop 2017-03-16T17:00:01+11:00 https://pharmadispatch.com/news/narrow-defeat-for-ex-ma-chief 2017-03-16T17:02:01+11:00 https://pharmadispatch.com/news/team-msd-in-front-with-one-day-to-go 2017-03-17T17:02:01+11:00 https://pharmadispatch.com/news/standstill-on-second-brand-as-ma-pushes-comparators 2017-03-17T17:01:01+11:00 https://pharmadispatch.com/news/trump-proposes-massive-cut-in-medical-research 2017-03-17T17:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-conquer-mt-kosi-challenge 2017-03-20T17:04:01+11:00 https://pharmadispatch.com/news/mixed-response-to-repatha-outcomes-data 2017-03-20T17:02:01+11:00 https://pharmadispatch.com/news/judge-slams-company-over-specious-evidence 2017-03-20T17:03:01+11:00 https://pharmadispatch.com/news/tga-reforms-one-step-closer 2017-03-20T17:01:01+11:00 https://pharmadispatch.com/news/bennelong-forum-hosts-dr-david-gillespie 2017-03-20T17:00:01+11:00 https://pharmadispatch.com/news/first-meeting-of-ma-advisory-council 2017-03-21T17:03:01+11:00 https://pharmadispatch.com/news/alphapharm-initiates-recall-of-epipen-batches 2017-03-21T17:02:01+11:00 https://pharmadispatch.com/news/real-world-study-backs-sglt-2-inhibitors 2017-03-21T17:01:01+11:00 https://pharmadispatch.com/news/labor-raises-penalty-rates-for-pharmacy-assistants 2017-03-21T17:00:01+11:00 https://pharmadispatch.com/news/us-frustration-with-australia-not-new 2017-03-22T17:03:01+11:00 https://pharmadispatch.com/news/china-boost-for-blackmores 2017-03-22T17:01:01+11:00 https://pharmadispatch.com/news/consumers-fundamental-to-health-system-reform 2017-03-22T17:02:01+11:00 https://pharmadispatch.com/news/xarelto-tops-aspirin-in-blood-clot-study 2017-03-22T17:00:01+11:00 https://pharmadispatch.com/news/consumers-back-pharmacy-administered-flu-vaccine 2017-03-23T17:04:01+11:00 https://pharmadispatch.com/news/turnbull-government-unveils-national-science-statement 2017-03-23T17:02:01+11:00 https://pharmadispatch.com/news/sinodinos-we-have-to-get-better-at-collaboration 2017-03-23T17:01:01+11:00 https://pharmadispatch.com/news/a-single-five-minute-car-trip 2017-03-23T17:03:01+11:00 https://pharmadispatch.com/news/no-pbs-intervention-for-medicinal-cannabis 2017-03-23T17:00:01+11:00 https://pharmadispatch.com/news/sigma-approaching-50-50-revenue-split 2017-03-24T17:03:01+11:00 https://pharmadispatch.com/news/just-when-the-system-looked-set-to-fail 2017-03-24T17:02:01+11:00 https://pharmadispatch.com/news/pbac-member-to-co-chair-new-mental-health-panel 2017-03-24T17:01:01+11:00 https://pharmadispatch.com/news/trump-were-going-to-try-and-have-the-lowest-prices-anywhere-in-t 2017-03-24T17:00:01+11:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-co-creation-and-partnership-the-only-op 2017-03-27T17:06:01+11:00 https://pharmadispatch.com/news/top-6-tips-overcoming-barriers-to-social-media-proactivity 2017-03-27T16:59:01+11:00 https://pharmadispatch.com/news/ma-ezetimibe-review-threat-to-pbs-reform-and-pbac-guidelines 2017-03-27T17:05:01+11:00 https://pharmadispatch.com/news/jj-joins-gsk-in-youtube-ban 2017-03-27T17:03:01+11:00 https://pharmadispatch.com/news/pbs-spike-moderates-as-confusion-reigns-over-rebates 2017-03-27T17:04:01+11:00 https://pharmadispatch.com/news/stakeholders-welcome-1-april-lymphoma-listing 2017-03-27T17:02:01+11:00 https://pharmadispatch.com/news/38-million-australian-adults-missing-out-on-free-vaccinations 2017-03-27T17:01:01+11:00 https://pharmadispatch.com/news/industry-looks-to-us-corporate-tax-cut 2017-03-28T17:00:01+11:00 https://pharmadispatch.com/news/senate-committee-backs-tga-reforms 2017-03-28T17:02:01+11:00 https://pharmadispatch.com/news/pm-praise-for-pharma-innovation 2017-03-28T17:01:01+11:00 https://pharmadispatch.com/news/exclusive-the-best-and-final-offer 2017-03-28T17:03:01+11:00 https://pharmadispatch.com/news/ma-in-advanced-talks-for-strategic-agreement-with-government 2017-03-29T17:02:01+11:00 https://pharmadispatch.com/news/is-the-horse-about-to-drink 2017-03-29T17:01:01+11:00 https://pharmadispatch.com/news/consultations-underway-on-australias-innovation-plan-to-2030 2017-03-31T17:00:01+11:00 https://pharmadispatch.com/news/an-agreement-is-worth-the-price 2017-03-29T17:00:01+11:00 https://pharmadispatch.com/news/signing-an-agreement-is-just-the-beginning 2017-03-30T17:02:01+11:00 https://pharmadispatch.com/news/here-comes-pbs-reform-lite-budget 2017-03-30T17:03:01+11:00 https://pharmadispatch.com/news/msd-welcomes-new-keytruda-approval 2017-03-30T17:01:01+11:00 https://pharmadispatch.com/news/guild-scraps-medsassist 2017-03-30T17:00:01+11:00 https://pharmadispatch.com/news/furious-minister-intervenes-on-medsassist 2017-03-31T17:02:01+11:00 https://pharmadispatch.com/news/msd-marks-brenzys-as-bdmards-deliver-savings-windfall 2017-03-31T17:01:01+11:00 https://pharmadispatch.com/news/rest-easy-on-tgps 2017-03-31T17:03:01+11:00 https://pharmadispatch.com/news/australia-free-riding-and-engaged-in-commercial-blackmail 2017-04-03T16:04:01+10:00 https://pharmadispatch.com/news/extraordinary-attack-reveals-true-feelings 2017-04-03T16:03:01+10:00 https://pharmadispatch.com/news/guild-welcomes-senate-support-for-tax-cuts 2017-04-03T16:00:01+10:00 https://pharmadispatch.com/news/biosimilars-front-and-centre 2017-04-03T16:02:01+10:00 https://pharmadispatch.com/news/a-case-of-timing-rather-than-new-saving 2017-04-04T16:04:01+10:00 https://pharmadispatch.com/news/rebates-in-the-us-undermining-patient-access 2017-04-04T16:03:01+10:00 https://pharmadispatch.com/news/ebos-company-buys-australian-rights-to-german-supplement-maker 2017-04-04T16:02:01+10:00 https://pharmadispatch.com/news/jj-confirms-new-name-for-actelion-assets 2017-04-04T16:01:01+10:00 https://pharmadispatch.com/news/story-telling-helps-people-understand-a-leading-cause-of-stroke 2017-04-04T16:00:01+10:00 https://pharmadispatch.com/news/changes-required-to-promote-sector-growth 2017-04-05T16:03:01+10:00 https://pharmadispatch.com/news/positive-survival-data-for-bms-immunotherapy-combination 2017-04-05T16:02:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-relaunches-product-for-cancer-patients 2017-04-05T16:00:01+10:00 https://pharmadispatch.com/news/roche-tops-brand-value-list 2017-04-05T16:01:01+10:00 https://pharmadispatch.com/news/exclusive-creating-a-medicines-future-fund 2017-04-06T16:00:01+10:00 https://pharmadispatch.com/news/further-evidence-of-extraordinary-transformation 2017-04-06T16:00:01+10:00 https://pharmadispatch.com/news/allergan-welcomes-new-launch 2017-04-06T16:00:01+10:00 https://pharmadispatch.com/news/high-courts-sticks-with-6m-fine 2017-04-06T16:00:01+10:00 https://pharmadispatch.com/news/may-listings-for-leukaemia-lung-disease-and-multiple-sclerosis 2017-04-07T16:03:01+10:00 https://pharmadispatch.com/news/rd-tax-proposal-will-cause-destruction 2017-04-07T16:02:01+10:00 https://pharmadispatch.com/news/extend-tga-gains-to-pbs-listing-process 2017-04-07T16:01:01+10:00 https://pharmadispatch.com/news/eu-trade-deal-opportunity-for-industry 2017-04-07T16:00:01+10:00 https://pharmadispatch.com/news/package-almost-finalised-as-concern-grows-over-funding-commitmen 2017-04-10T16:04:01+10:00 https://pharmadispatch.com/news/government-set-to-act-on-biosimilar-uptake 2017-04-10T16:03:01+10:00 https://pharmadispatch.com/news/an-agreement-worth-the-price 2017-04-10T16:02:01+10:00 https://pharmadispatch.com/news/psa-calls-for-pharmacy-pay-rise 2017-04-10T16:01:01+10:00 https://pharmadispatch.com/news/asmi-calls-for-new-wave-of-reform 2017-04-10T16:00:01+10:00 https://pharmadispatch.com/news/where-will-the-money-go 2017-04-11T16:03:01+10:00 https://pharmadispatch.com/news/ma-welcomes-launch-of-commercialisation-program 2017-04-11T16:01:01+10:00 https://pharmadispatch.com/news/new-leadership-for-farmaforce 2017-04-11T16:00:01+10:00 https://pharmadispatch.com/news/department-creates-new-hta-consumer-committee 2017-04-11T16:02:01+10:00 https://pharmadispatch.com/news/new-pbs-report-not-quite-timed-to-perfection 2017-04-12T16:02:01+10:00 https://pharmadispatch.com/news/possible-d-day-for-pbs-budget-package 2017-04-12T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-prota-therapeutics 2017-04-12T16:01:01+10:00 https://pharmadispatch.com/news/mesoblast-progresses-phase-3-trial 2017-04-12T16:00:01+10:00 https://pharmadispatch.com/news/prescribing-game-changer 2017-04-13T16:03:01+10:00 https://pharmadispatch.com/news/idt-reports-better-than-expected-sales-result 2017-04-13T16:00:01+10:00 https://pharmadispatch.com/news/progress-possible-on-key-issue 2017-04-13T16:02:01+10:00 https://pharmadispatch.com/news/need-to-understand-impact-of-shortage 2017-04-13T16:01:01+10:00 https://pharmadispatch.com/news/does-international-comparison-reveal-reason-for-new-uptake-drive 2017-04-18T16:04:01+10:00 https://pharmadispatch.com/news/dispute-over-lease-threatens-cancer-research 2017-04-18T16:01:01+10:00 https://pharmadispatch.com/news/no-australian-impact-for-us-gilenya-decision 2017-04-19T16:02:01+10:00 https://pharmadispatch.com/news/queensland-points-to-lower-hiv-notification-rate 2017-04-18T16:00:01+10:00 https://pharmadispatch.com/news/australia-failing-to-implement-trade-obligations 2017-04-18T16:02:01+10:00 https://pharmadispatch.com/news/sector-unites-against-rd-tax-change 2017-04-18T16:03:01+10:00 https://pharmadispatch.com/news/one-step-at-a-time-on-reform-package 2017-04-19T16:03:01+10:00 https://pharmadispatch.com/news/terrywhite-chemmart-reports-record-demand-for-flu-shot 2017-04-19T16:01:01+10:00 https://pharmadispatch.com/news/api-relaunches-larges-health-and-beauty-loyalty-program 2017-04-19T16:00:01+10:00 https://pharmadispatch.com/news/pre-budget-almost-done-for-greg-hunt 2017-04-20T16:04:01+10:00 https://pharmadispatch.com/news/approval-for-csls-afstyla 2017-04-20T16:01:01+10:00 https://pharmadispatch.com/news/sector-concern-over-scrapping-of-457-visas 2017-04-20T16:03:01+10:00 https://pharmadispatch.com/news/ip-australia-delays-legislation 2017-04-20T16:02:01+10:00 https://pharmadispatch.com/news/merck-supports-new-cancer-fellowship 2017-04-20T16:00:01+10:00 https://pharmadispatch.com/news/priceline-growth-the-standout-for-api 2017-04-21T16:02:01+10:00 https://pharmadispatch.com/news/cancer-medicines-to-headline-pbac-outcomes 2017-04-21T16:04:01+10:00 https://pharmadispatch.com/news/time-and-consultation-will-come 2017-04-21T16:05:01+10:00 https://pharmadispatch.com/news/pfizer-pads-up-on-support-of-mcgrath-foundation 2017-04-21T16:01:01+10:00 https://pharmadispatch.com/news/supply-chain-award-for-symbion 2017-04-21T16:00:01+10:00 https://pharmadispatch.com/news/starpharma-striggers-milestone-payment-from-az 2017-04-21T16:03:01+10:00 https://pharmadispatch.com/news/pbac-recommends-key-cancer-therapies 2017-04-21T20:30:01+10:00 https://pharmadispatch.com/news/the-future-of-managed-entry 2017-04-24T16:04:01+10:00 https://pharmadispatch.com/news/budget-key-for-mrff 2017-04-24T16:02:01+10:00 https://pharmadispatch.com/news/outcomes-reveal-gsk-pricing-victory 2017-04-24T16:03:01+10:00 https://pharmadispatch.com/news/steve-waugh-to-mark-apo-wellness-milestone 2017-04-24T16:00:01+10:00 https://pharmadispatch.com/news/government-to-take-on-anti-vaxxers-in-new-campaign 2017-04-24T16:01:01+10:00 https://pharmadispatch.com/news/action-on-comparators-will-take-time-and-trade-offs 2017-04-26T16:04:01+10:00 https://pharmadispatch.com/news/pre-rebate-still-growth-high-but-slowing 2017-04-26T16:02:01+10:00 https://pharmadispatch.com/news/disappointing-trial-result-for-sirtex 2017-04-26T16:00:01+10:00 https://pharmadispatch.com/news/pbs-price-watch-on-diabetes-medicines 2017-04-26T16:03:01+10:00 https://pharmadispatch.com/news/lsdp-wait-goes-on-and-on 2017-04-27T16:00:01+10:00 https://pharmadispatch.com/news/retirement-for-ex-ma-board-member 2017-04-26T16:01:01+10:00 https://pharmadispatch.com/news/some-surprises-for-july-pbac 2017-04-27T16:02:01+10:00 https://pharmadispatch.com/news/negotiations-finalised-as-ma-seeks-member-support 2017-04-27T16:03:01+10:00 https://pharmadispatch.com/news/move-for-senior-ministerial-adviser 2017-04-27T16:01:01+10:00 https://pharmadispatch.com/news/agreement-started-as-a-dance 2017-04-28T16:03:01+10:00 https://pharmadispatch.com/news/late-changes-but-few-surprises-to-come 2017-04-28T16:02:01+10:00 https://pharmadispatch.com/news/five-trends-to-watch-in-pharma-marketing 2017-04-28T16:01:01+10:00 https://pharmadispatch.com/news/uk-industry-calls-for-investment-in-new-medicines 2017-04-29T04:00:01+10:00 https://pharmadispatch.com/news/ma-negotiates-solution-on-second-brand 2017-05-01T16:03:01+10:00 https://pharmadispatch.com/news/fund-will-be-there-but-may-not-be-transparent 2017-05-02T16:04:01+10:00 https://pharmadispatch.com/news/patients-will-suffer-if-we-dont-the-get-revenue-structure-right 2017-05-01T16:04:01+10:00 https://pharmadispatch.com/news/msds-statement-of-intent-on-biosimilars 2017-05-01T16:02:01+10:00 https://pharmadispatch.com/news/pharmac-to-fund-therapy-that-makes-brain-tumours-fluorescent 2017-05-01T16:01:01+10:00 https://pharmadispatch.com/news/new-research-released-for-kiss-goodbye-to-ms 2017-05-01T16:00:01+10:00 https://pharmadispatch.com/news/ustr-gives-mixed-message-on-australia 2017-05-02T16:02:01+10:00 https://pharmadispatch.com/news/optimism-impacted-by-concerns-over-rd-tax-incentive 2017-05-02T16:03:01+10:00 https://pharmadispatch.com/news/ministers-act-on-immunisation-change 2017-05-02T16:01:01+10:00 https://pharmadispatch.com/news/high-expectations-hurt-mayne-pharma 2017-05-02T16:00:01+10:00 https://pharmadispatch.com/news/budget-win-for-heart-failure-patients 2017-05-03T16:00:01+10:00 https://pharmadispatch.com/news/ceo-for-university-backed-drug-development-joint-venture 2017-05-03T16:00:01+10:00 https://pharmadispatch.com/news/acquisition-for-george-clinical 2017-05-03T16:00:01+10:00 https://pharmadispatch.com/news/diversity-boosts-gsk-result 2017-05-03T16:00:01+10:00 https://pharmadispatch.com/news/no-therapeutic-groups-but-no-respite-on-reviews 2017-05-04T16:03:01+10:00 https://pharmadispatch.com/news/members-remain-the-focus-for-ma 2017-05-04T16:02:01+10:00 https://pharmadispatch.com/news/department-getting-better-at-engaging-stakeholders 2017-05-04T16:01:01+10:00 https://pharmadispatch.com/news/mtpconnect-funding-call 2017-05-04T16:00:01+10:00 https://pharmadispatch.com/news/brands-far-from-gone-under-software-change 2017-05-05T16:00:01+10:00 https://pharmadispatch.com/news/five-plus-five-for-second-brands 2017-05-05T14:11:01+10:00 https://pharmadispatch.com/news/agreements-done-as-sector-waits-for-budget 2017-05-05T16:00:01+10:00 https://pharmadispatch.com/news/nz-waiting-list-continues-to-grow 2017-05-05T16:00:01+10:00 https://pharmadispatch.com/news/change-to-support-stability-of-supply 2017-05-08T16:04:01+10:00 https://pharmadispatch.com/news/parliament-to-have-final-say-on-reforms 2017-05-08T16:03:01+10:00 https://pharmadispatch.com/news/australia-targeted-in-us-trade-review 2017-05-08T16:00:01+10:00 https://pharmadispatch.com/news/funding-welcome-but-time-to-clear-the-waiting-list 2017-05-08T16:01:01+10:00 https://pharmadispatch.com/news/just-talk-as-industry-gets-on-with-innovating 2017-05-08T16:02:01+10:00 https://pharmadispatch.com/news/a-day-of-few-surprises-maybe 2017-05-09T16:03:01+10:00 https://pharmadispatch.com/news/pbac-appointments-move-closer 2017-05-09T16:02:01+10:00 https://pharmadispatch.com/news/what-now-for-rd-tax-incentive 2017-05-09T16:01:01+10:00 https://pharmadispatch.com/news/new-pharmac-funding-proposals 2017-05-09T16:00:01+10:00 https://pharmadispatch.com/news/agreements-reveal-some-surprises 2017-05-10T05:30:01+10:00 https://pharmadispatch.com/news/cook-we-had-unfinished-business 2017-05-10T05:30:01+10:00 https://pharmadispatch.com/news/belinda-wood-we-were-prepared 2017-05-10T05:30:01+10:00 https://pharmadispatch.com/news/wholesalers-welcome-budget-but-looking-to-long-term-solution 2017-05-10T05:00:01+10:00 https://pharmadispatch.com/news/budget-2017-18-the-measures-and-key-points 2017-05-10T16:05:01+10:00 https://pharmadispatch.com/news/industry-leaders-welcome-budget 2017-05-10T16:03:01+10:00 https://pharmadispatch.com/news/a-let-off-for-rd-tax-incentive 2017-05-10T16:01:01+10:00 https://pharmadispatch.com/news/research-australia-welcomes-first-mrff-grants 2017-05-10T16:00:01+10:00 https://pharmadispatch.com/news/guild-welcomes-budget-but-psa-says-missed-opportunity 2017-05-10T16:02:01+10:00 https://pharmadispatch.com/news/novartis-welcomes-entresto-listing 2017-05-10T16:04:01+10:00 https://pharmadispatch.com/news/transformation-and-the-shift-in-sustainability 2017-05-11T16:04:01+10:00 https://pharmadispatch.com/news/comparing-uptake-not-so-simple 2017-05-11T16:03:01+10:00 https://pharmadispatch.com/news/new-role-for-ex-gsk-boss 2017-05-11T16:00:01+10:00 https://pharmadispatch.com/news/recognition-for-gsk-manufacturing-innovator 2017-05-11T16:01:01+10:00 https://pharmadispatch.com/news/mpa-welcomes-budget-changes 2017-05-11T16:02:01+10:00 https://pharmadispatch.com/news/ministerial-praise-for-fundamental-bodies 2017-05-12T16:05:01+10:00 https://pharmadispatch.com/news/jj-funds-scholarships-for-indigenous-surgeons 2017-05-12T16:00:01+10:00 https://pharmadispatch.com/news/ex-az-chief-takes-senior-role-at-grnenthal 2017-05-13T04:02:01+10:00 https://pharmadispatch.com/news/pharmaceutical-innovation-transforms-hiv-diagnosis 2017-05-12T16:01:01+10:00 https://pharmadispatch.com/news/pbs-front-of-pms-health-agenda 2017-05-12T16:03:01+10:00 https://pharmadispatch.com/news/its-about-trust-and-mutual-respect 2017-05-15T16:04:01+10:00 https://pharmadispatch.com/news/biologics-pbs-share-on-the-rise 2017-05-15T16:02:01+10:00 https://pharmadispatch.com/news/first-generics-of-gsks-seretide-in-june 2017-05-15T16:03:01+10:00 https://pharmadispatch.com/news/private-launch-for-msd-insomnia-therapy 2017-05-15T16:01:01+10:00 https://pharmadispatch.com/news/az-stakes-immunotherapy-claim 2017-05-15T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-hosts-hackathon-to-support-smith-family 2017-05-16T16:02:01+10:00 https://pharmadispatch.com/news/bi-extends-development-of-pharmaxis-compound 2017-05-16T16:01:01+10:00 https://pharmadispatch.com/news/research-reveals-vaccination-apathy 2017-05-16T16:04:01+10:00 https://pharmadispatch.com/news/nominations-for-gsk-award-now-open 2017-05-16T16:00:01+10:00 https://pharmadispatch.com/news/gsk-to-acquire-novartis-consumer-health-stake 2017-05-16T16:03:01+10:00 https://pharmadispatch.com/news/priceline-teams-up-with-stroke-foundation 2017-05-17T16:01:01+10:00 https://pharmadispatch.com/news/australian-company-initiates-trial-of-peanut-allergy-treatment 2017-05-17T16:00:01+10:00 https://pharmadispatch.com/news/no-vacancy-sign-for-pbac 2017-05-17T16:03:01+10:00 https://pharmadispatch.com/news/az-and-gsk-in-battle-over-australian-executive 2017-05-17T16:02:01+10:00 https://pharmadispatch.com/news/there-must-be-an-election-in-the-air 2017-05-18T16:04:01+10:00 https://pharmadispatch.com/news/specialised-therapeutics-adds-compound-to-portfolio 2017-05-18T16:03:01+10:00 https://pharmadispatch.com/news/amazon-planning-move-into-pharmacy 2017-05-18T16:02:01+10:00 https://pharmadispatch.com/news/jj-announces-new-actelion-leadership 2017-05-18T16:01:01+10:00 https://pharmadispatch.com/news/new-products-to-drive-jj-growth 2017-05-18T16:00:01+10:00 https://pharmadispatch.com/news/review-is-dead-on-arrival 2017-05-19T16:00:01+10:00 https://pharmadispatch.com/news/affirmative-action-required-to-close-survival-gap 2017-05-19T16:00:01+10:00 https://pharmadispatch.com/news/australia-study-backs-extended-use-of-bms-combination 2017-05-19T16:00:01+10:00 https://pharmadispatch.com/news/patient-treatment-commences-in-cynata-clinical-trial 2017-05-19T16:00:01+10:00 https://pharmadispatch.com/news/tpp-now-tpp11 2017-05-22T16:02:01+10:00 https://pharmadispatch.com/news/what-now-for-ezetimibe-review 2017-05-22T16:04:01+10:00 https://pharmadispatch.com/news/funding-boost-for-clinical-trials 2017-05-22T16:01:01+10:00 https://pharmadispatch.com/news/amgen-welcomes-new-government-investment 2017-05-22T16:00:01+10:00 https://pharmadispatch.com/news/the-funding-envelope-as-the-future 2017-05-22T16:03:01+10:00 https://pharmadispatch.com/news/clinical-trials-alliance-thanks-minister 2017-05-23T16:02:01+10:00 https://pharmadispatch.com/news/whos-using-uber 2017-05-24T04:03:01+10:00 https://pharmadispatch.com/news/mining-magnate-commits-75m-to-cancer-research 2017-05-23T16:01:01+10:00 https://pharmadispatch.com/news/prep-trial-reports-first-hiv-diagnosis 2017-05-23T16:00:01+10:00 https://pharmadispatch.com/news/ebos-acquires-hospital-pharmacy-service-provider 2017-05-24T16:01:01+10:00 https://pharmadispatch.com/news/msd-slams-ezetimibe-review-report 2017-05-24T16:03:01+10:00 https://pharmadispatch.com/news/new-investment-for-local-biotech 2017-05-24T16:00:01+10:00 https://pharmadispatch.com/news/minister-commends-sector 2017-05-24T16:02:01+10:00 https://pharmadispatch.com/news/an-utterly-pointless-exercise 2017-05-25T16:04:01+10:00 https://pharmadispatch.com/news/ubs-sigma-case-raises-wider-issues 2017-05-25T16:01:01+10:00 https://pharmadispatch.com/news/parliamentary-hold-up-impacts-tga-review-changes 2017-05-25T16:02:01+10:00 https://pharmadispatch.com/news/doing-better-than-we-think-on-clinical-trials 2017-05-25T16:00:01+10:00 https://pharmadispatch.com/news/department-creates-office-of-hta 2017-05-26T16:04:01+10:00 https://pharmadispatch.com/news/visa-changes-a-disaster-for-life-sciences 2017-05-26T16:02:01+10:00 https://pharmadispatch.com/news/massive-underspend-in-biosimilar-awareness-initiative 2017-05-26T16:03:01+10:00 https://pharmadispatch.com/news/complex-story-for-biosimilar-price-cuts 2017-05-26T16:01:01+10:00 https://pharmadispatch.com/news/approval-for-allergans-double-chin-injectable 2017-05-26T16:00:01+10:00 https://pharmadispatch.com/news/changing-mood-on-clinical-trials 2017-05-29T16:03:01+10:00 https://pharmadispatch.com/news/department-clarifies-pbac-role-in-lsdp 2017-05-29T16:02:01+10:00 https://pharmadispatch.com/news/new-pbac-members 2017-05-29T16:04:01+10:00 https://pharmadispatch.com/news/minister-commends-australian-first 2017-05-29T16:00:01+10:00 https://pharmadispatch.com/news/fda-chief-unveils-price-plans 2017-05-29T16:01:01+10:00 https://pharmadispatch.com/news/did-pbac-really-stop-making-lsdp-recommendations-in-2012 2017-05-30T16:03:01+10:00 https://pharmadispatch.com/news/pbs-at-budget-estimates 2017-05-30T16:04:01+10:00 https://pharmadispatch.com/news/dont-worry-we-took-a-screenshot 2017-05-30T16:02:01+10:00 https://pharmadispatch.com/news/new-job-for-ex-chf-ceo 2017-05-30T16:00:01+10:00 https://pharmadispatch.com/news/entresto-to-combat-rising-heart-failure-burden 2017-05-30T16:01:01+10:00 https://pharmadispatch.com/news/canteen-looking-for-industry-partners 2017-06-02T16:03:01+10:00 https://pharmadispatch.com/news/labor-will-not-list-medicines-claims-turnbull 2017-05-31T16:04:01+10:00 https://pharmadispatch.com/news/major-investor-backs-australian-research 2017-05-31T16:01:01+10:00 https://pharmadispatch.com/news/cut-out-the-nagging 2017-05-31T16:02:01+10:00 https://pharmadispatch.com/news/baxter-partners-with-hospital-on-sustainability-initiative-1 2017-05-31T16:00:01+10:00 https://pharmadispatch.com/news/cancer-patient-makes-governments-health-defence 2017-05-31T16:03:01+10:00 https://pharmadispatch.com/news/janssen-signs-new-agreement-with-australian-biotech 2017-06-01T16:03:01+10:00 https://pharmadispatch.com/news/australia-tops-global-pain-index-1 2017-06-01T16:02:01+10:00 https://pharmadispatch.com/news/bms-adds-another-opdivo-indication 2017-06-01T16:04:01+10:00 https://pharmadispatch.com/news/merck-funding-for-ms-scholarship 2017-06-01T16:01:01+10:00 https://pharmadispatch.com/news/symbion-fires-employee-over-tampering-allegations 2017-06-01T16:00:01+10:00 https://pharmadispatch.com/news/applications-open-for-csl-fellowship-1 2017-06-02T16:02:01+10:00 https://pharmadispatch.com/news/ma-welcomes-increases-consumer-presence-on-pbac 2017-06-02T16:04:01+10:00 https://pharmadispatch.com/news/more-bexsero-for-australian-market 2017-06-02T16:01:01+10:00 https://pharmadispatch.com/news/nice-recommends-keytruda-for-cancer-drugs-fund 2017-06-02T16:00:01+10:00 https://pharmadispatch.com/news/sinodinos-cabinet-has-considered-ip-changes 2017-06-05T16:02:01+10:00 https://pharmadispatch.com/news/former-pbs-official-joins-az 2017-06-05T16:03:01+10:00 https://pharmadispatch.com/news/greg-hunt-is-the-one-who-should-be-frustrated 2017-06-05T16:04:01+10:00 https://pharmadispatch.com/news/another-australian-collaboration-for-janssen 2017-06-05T16:01:01+10:00 https://pharmadispatch.com/news/ireland-says-yes-to-orkambi 2017-06-05T16:00:01+10:00 https://pharmadispatch.com/news/budget-funding-leaves-unfinished-business-for-wholesalers-and-pa 2017-06-06T16:03:01+10:00 https://pharmadispatch.com/news/bruce-goodwin-more-investment-to-come-but-policy-matters 2017-06-06T16:02:01+10:00 https://pharmadispatch.com/news/guild-welcomes-balanced-decision-on-penalty-rates 2017-06-06T16:01:01+10:00 https://pharmadispatch.com/news/worlds-most-decorated-olympian-joins-medibio-board 2017-06-06T16:00:01+10:00 https://pharmadispatch.com/news/novartis-and-bms-team-up-for-new-trial 2017-06-07T16:02:01+10:00 https://pharmadispatch.com/news/current-system-inherently-inefficient-for-rare-cancers 2017-06-07T16:03:01+10:00 https://pharmadispatch.com/news/abbvie-tops-pharma-reputation-index 2017-06-07T16:01:01+10:00 https://pharmadispatch.com/news/investment-for-another-uniquest-spinout 2017-06-07T16:00:01+10:00 https://pharmadispatch.com/news/industry-gathers-for-bridge-program-launch 2017-06-08T16:03:01+10:00 https://pharmadispatch.com/news/visa-changes-could-impact-industry-leadership 2017-06-08T16:01:01+10:00 https://pharmadispatch.com/news/these-companies-do-give-back-to-the-eco-system 2017-06-08T16:02:01+10:00 https://pharmadispatch.com/news/quilty-consumers-backing-pharmacy-vaccination 2017-06-08T16:00:01+10:00 https://pharmadispatch.com/news/new-board-appointment-for-pharmaxis 2017-06-09T16:02:01+10:00 https://pharmadispatch.com/news/investment-relies-on-the-eco-system 2017-06-09T16:04:01+10:00 https://pharmadispatch.com/news/keytruda-delivers-overall-survival-benefit 2017-06-09T16:03:01+10:00 https://pharmadispatch.com/news/pfizer-donors-aim-to-become-bloody-legends 2017-06-09T16:00:01+10:00 https://pharmadispatch.com/news/report-highlights-importance-of-affordable-medicines 2017-06-09T16:01:01+10:00 https://pharmadispatch.com/news/novartis-recruit-australian-industry-leader-for-major-global-rol 2017-06-13T16:00:01+10:00 https://pharmadispatch.com/news/recognition-for-policy-maker-for-hcv 2017-06-13T16:00:01+10:00 https://pharmadispatch.com/news/puppy-love-for-bayer-employees 2017-06-13T16:00:01+10:00 https://pharmadispatch.com/news/valeant-reduced-debt-with-inova-sale 2017-06-12T20:53:01+10:00 https://pharmadispatch.com/news/never-thought-i-would-see-the-day 2017-06-13T16:00:01+10:00 https://pharmadispatch.com/news/csl-acquires-strategic-stake-in-chinese-company 2017-06-14T16:00:01+10:00 https://pharmadispatch.com/news/label-change-for-epipen 2017-06-14T16:02:01+10:00 https://pharmadispatch.com/news/pharmaxis-to-advance-bronchitol-in-the-us 2017-06-14T16:01:01+10:00 https://pharmadispatch.com/news/hospital-pharmacists-demand-urgent-improvements 2017-06-14T16:03:01+10:00 https://pharmadispatch.com/news/progress-on-cancer-access-but-more-work-required 2017-06-15T04:04:01+10:00 https://pharmadispatch.com/news/miner-grabs-leading-industry-communicator 2017-06-15T16:03:01+10:00 https://pharmadispatch.com/news/pfizer-clarifies-ibrance-access 2017-06-15T16:02:01+10:00 https://pharmadispatch.com/news/surgery-not-the-only-option-for-prostate-cancer 2017-06-15T16:01:01+10:00 https://pharmadispatch.com/news/starpharma-sells-agrochemicals-business 2017-06-15T16:00:01+10:00 https://pharmadispatch.com/news/is-there-a-story-behind-the-shortages 2017-06-16T16:04:01+10:00 https://pharmadispatch.com/news/new-therapy-added-but-still-no-news-on-lsdp-future 2017-06-15T16:04:01+10:00 https://pharmadispatch.com/news/may-listings-for-rare-cancer-and-lung-disease 2017-06-16T16:02:01+10:00 https://pharmadispatch.com/news/clinicians-slam-cochrane-over-hcv-report 2017-06-16T16:01:01+10:00 https://pharmadispatch.com/news/phi-moves-into-pharmaceutical-benefits 2017-06-16T16:00:01+10:00 https://pharmadispatch.com/news/pricing-a-risk-to-sustainable-supply 2017-06-16T16:03:01+10:00 https://pharmadispatch.com/news/company-face-off-does-to-aat 2017-06-19T16:04:01+10:00 https://pharmadispatch.com/news/first-price-disclosure-reductions-for-key-medicines 2017-06-19T16:03:01+10:00 https://pharmadispatch.com/news/jj-completes-actelion-acquisition 2017-06-19T16:02:01+10:00 https://pharmadispatch.com/news/sigma-subsidiary-wins-defence-contract 2017-06-19T16:01:01+10:00 https://pharmadispatch.com/news/venture-capital-raised-soars-but-still-a-long-way-to-go 2017-06-19T16:00:01+10:00 https://pharmadispatch.com/news/inflectra-case-goes-into-day-two 2017-06-20T16:05:01+10:00 https://pharmadispatch.com/news/consultancy-returning-to-its-roots 2017-06-20T16:03:01+10:00 https://pharmadispatch.com/news/maybe-biosimilars-can-deliver-on-price-disclosure 2017-06-19T16:04:01+10:00 https://pharmadispatch.com/news/australia-first-genetic-test-launched-today 2017-06-20T16:01:01+10:00 https://pharmadispatch.com/news/new-campaign-for-return-unwanted-medicines 2017-06-20T16:00:01+10:00 https://pharmadispatch.com/news/az-and-gsk-settle-over-australian-executive 2017-06-20T16:02:01+10:00 https://pharmadispatch.com/news/new-peak-body-for-medical-cannabis-industry 2017-06-22T16:00:01+10:00 https://pharmadispatch.com/news/aat-delivers-inflectra-pi-decision 2017-06-21T16:03:01+10:00 https://pharmadispatch.com/news/still-waiting-on-two-pbac-appointments 2017-06-21T16:02:01+10:00 https://pharmadispatch.com/news/parkinsons-dataset-reveals-variation-across-markets 2017-06-21T16:00:01+10:00 https://pharmadispatch.com/news/ian-frazer-to-speak-at-medicines-nz-dinner 2017-06-21T16:01:01+10:00 https://pharmadispatch.com/news/sector-waits-for-pharmacy-review-report 2017-06-22T16:00:01+10:00 https://pharmadispatch.com/news/crunch-time-on-working-visa-changes 2017-06-22T15:03:01+10:00 https://pharmadispatch.com/news/european-ruling-threatens-drug-development 2017-06-22T16:00:01+10:00 https://pharmadispatch.com/news/mtpconnect-clinical-trials-add-11bn-to-economy 2017-06-23T16:00:01+10:00 https://pharmadispatch.com/news/breaking-news-pharmacy-review-report 2017-06-22T21:40:01+10:00 https://pharmadispatch.com/news/new-president-for-psa 2017-06-23T16:00:01+10:00 https://pharmadispatch.com/news/stakeholder-response-to-pharmacy-review-report 2017-06-23T03:54:01+10:00 https://pharmadispatch.com/news/how-is-forcing-consumers-to-pay-more-a-good-thing 2017-06-23T16:00:01+10:00 https://pharmadispatch.com/news/tsunami-of-change-coming 2017-06-26T16:04:01+10:00 https://pharmadispatch.com/news/australia-set-to-be-targeted-in-trump-global-drug-review 2017-06-26T16:03:01+10:00 https://pharmadispatch.com/news/accolade-for-seqirus-manufacturing-leader 2017-06-26T16:02:01+10:00 https://pharmadispatch.com/news/manufacturers-unite-on-reports-key-recommendations 2017-06-25T16:01:01+10:00 https://pharmadispatch.com/news/apotex-launches-vaccine-ordering-website 2017-06-26T16:00:01+10:00 https://pharmadispatch.com/news/new-alliance-calls-for-action-on-osteoporosis 2017-06-27T16:02:01+10:00 https://pharmadispatch.com/news/chf-price-changes-not-the-answer 2017-06-27T16:04:01+10:00 https://pharmadispatch.com/news/unified-opposition-signals-report-death-knell 2017-06-27T16:03:01+10:00 https://pharmadispatch.com/news/merck-working-towards-access-for-ms-therapy 2017-06-27T16:00:01+10:00 https://pharmadispatch.com/news/funding-for-project-looking-to-link-datasets 2017-06-27T16:01:01+10:00 https://pharmadispatch.com/news/new-leadership-for-servier 2017-06-28T16:02:01+10:00 https://pharmadispatch.com/news/merck-announces-global-research-collaboration 2017-06-28T16:01:01+10:00 https://pharmadispatch.com/news/rising-tensions-over-pricing-agreements 2017-06-28T16:03:01+10:00 https://pharmadispatch.com/news/blackmores-loses-ceo-to-australia-post 2017-06-28T16:00:01+10:00 https://pharmadispatch.com/news/terry-white-partners-for-aged-care-medication-system 2017-06-28T20:02:01+10:00 https://pharmadispatch.com/news/what-do-changes-to-rebate-policy-mean-for-mas-strategic-agreemen 2017-06-29T16:03:01+10:00 https://pharmadispatch.com/news/whats-in-a-deed 2017-06-29T16:02:01+10:00 https://pharmadispatch.com/news/msd-yet-to-decide-on-cetp-inhibitor 2017-06-29T16:01:01+10:00 https://pharmadispatch.com/news/now-is-the-time-for-an-angry-letter 2017-06-29T16:04:01+10:00 https://pharmadispatch.com/news/a-week-of-possibilities-at-abbvie 2017-06-30T16:02:01+10:00 https://pharmadispatch.com/news/wholesalers-looking-for-long-term-stability 2017-06-30T16:01:01+10:00 https://pharmadispatch.com/news/d-day-approaching-for-working-visa-changes 2017-06-30T16:03:01+10:00 https://pharmadispatch.com/news/concern-over-cost-recovery-changes 2017-06-29T16:04:01+10:00 https://pharmadispatch.com/news/sirtex-confirms-guidance-but-announces-restructure 2017-06-30T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-biogen 2017-07-03T16:04:01+10:00 https://pharmadispatch.com/news/turnbull-government-backflip-on-visa-changes 2017-07-03T16:05:01+10:00 https://pharmadispatch.com/news/pbac-not-giving-up-on-biomarker-test-for-anti-pd1 2017-07-03T16:02:01+10:00 https://pharmadispatch.com/news/how-long-will-the-money-last 2017-07-04T16:02:01+10:00 https://pharmadispatch.com/news/australians-not-protected-on-holdays 2017-07-03T16:01:01+10:00 https://pharmadispatch.com/news/spending-on-hcos-continues-to-fall 2017-07-03T16:03:01+10:00 https://pharmadispatch.com/news/apotex-launches-new-vitamin-range 2017-07-03T16:00:01+10:00 https://pharmadispatch.com/news/abbvie-welcomes-new-humira-listing 2017-07-04T16:00:01+10:00 https://pharmadispatch.com/news/industry-still-waiting-on-pbac-appointment 2017-07-04T16:03:01+10:00 https://pharmadispatch.com/news/ma-welcomes-visa-changes 2017-07-04T16:01:01+10:00 https://pharmadispatch.com/news/australian-biotech-appoints-us-political-heir 2017-07-05T16:02:01+10:00 https://pharmadispatch.com/news/here-we-go-again 2017-07-05T16:03:01+10:00 https://pharmadispatch.com/news/its-ludicrous-says-medicines-australia 2017-07-05T16:01:01+10:00 https://pharmadispatch.com/news/more-news-for-sirtex 2017-07-05T16:00:01+10:00 https://pharmadispatch.com/news/budget-office-forecast-overstates-pbs-spend 2017-07-06T16:02:01+10:00 https://pharmadispatch.com/news/waiting-on-biosimilar-next-steps 2017-07-06T16:03:01+10:00 https://pharmadispatch.com/news/report-should-send-shock-waves-through-health-system 2017-07-06T16:01:01+10:00 https://pharmadispatch.com/news/suda-inks-zolpimist-deal-with-teva 2017-07-06T16:00:01+10:00 https://pharmadispatch.com/news/ministers-try-to-ease-brexit-concerns 2017-07-07T16:00:01+10:00 https://pharmadispatch.com/news/department-of-health-to-watch-for-new-technologies 2017-07-07T16:03:01+10:00 https://pharmadispatch.com/news/putting-medicines-costs-in-context 2017-07-07T16:01:01+10:00 https://pharmadispatch.com/news/sigma-not-giving-up-on-pathology-program 2017-07-07T16:02:01+10:00 https://pharmadispatch.com/news/sector-cynical-about-rort-claims 2017-07-10T16:03:01+10:00 https://pharmadispatch.com/news/celgene-acquires-rights-to-pd-1-inhibitor 2017-07-10T16:01:01+10:00 https://pharmadispatch.com/news/australia-and-eu-to-push-trade-deal 2017-07-10T16:00:01+10:00 https://pharmadispatch.com/news/august-meeting-for-industry-nomination 2017-07-10T16:02:01+10:00 https://pharmadispatch.com/news/single-complaints-body-for-advertising-complaints 2017-07-10T16:04:01+10:00 https://pharmadispatch.com/news/how-times-have-changed-1 2017-07-11T16:03:01+10:00 https://pharmadispatch.com/news/south-australia-appoints-venture-capital-fund 2017-07-11T16:01:01+10:00 https://pharmadispatch.com/news/gps-ignoring-antibiotic-guidelines 2017-07-11T16:02:01+10:00 https://pharmadispatch.com/news/government-reviews-medicare-breach 2017-07-11T16:00:01+10:00 https://pharmadispatch.com/news/we-cant-afford-not-to-be-part-of-the-discussion 2017-07-17T16:00:01+10:00 https://pharmadispatch.com/news/az-to-invest-100m-in-australian-manufacturing 2017-07-12T16:00:01+10:00 https://pharmadispatch.com/news/uk-expansion-for-australian-poppy-processor 2017-07-12T16:01:01+10:00 https://pharmadispatch.com/news/uk-industry-starts-legal-action-against-new-spending-hurdle 2017-07-12T16:00:01+10:00 https://pharmadispatch.com/news/devil-in-the-detail-on-advertising-change 2017-07-12T16:00:01+10:00 https://pharmadispatch.com/news/industry-pbac-nomination-finally-revealed 2017-07-13T16:04:01+10:00 https://pharmadispatch.com/news/major-acquisition-for-australian-poppy-processor 2017-07-13T16:01:01+10:00 https://pharmadispatch.com/news/study-confirms-efficacy-of-pradaxa-reversal-agent 2017-07-13T16:02:01+10:00 https://pharmadispatch.com/news/dusc-outcomes-on-crohns-and-migraine 2017-07-13T16:03:01+10:00 https://pharmadispatch.com/news/pfeiffenberger-great-news-for-patients 2017-07-31T16:05:01+10:00 https://pharmadispatch.com/news/seventh-indication-for-opdivo 2017-07-13T16:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-az-manufacturing-investment 2017-07-14T16:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-pbac-appointment 2017-07-14T16:00:01+10:00 https://pharmadispatch.com/news/victorian-pharma-and-medtech-booming 2017-07-14T16:00:01+10:00 https://pharmadispatch.com/news/the-irony-of-soriots-departure-from-az 2017-07-14T04:06:01+10:00 https://pharmadispatch.com/news/soriot-sticking-with-astrazeneca 2017-07-17T16:00:01+10:00 https://pharmadispatch.com/news/affordability-of-medicines-an-issue-for-australian-patients 2017-07-17T16:00:01+10:00 https://pharmadispatch.com/news/idt-announces-departure-of-ceo 2017-07-17T16:00:01+10:00 https://pharmadispatch.com/news/tension-rising-after-submission-cap 2017-07-17T16:01:01+10:00 https://pharmadispatch.com/news/ustr-acting-on-trade-agreements 2017-07-18T16:02:01+10:00 https://pharmadispatch.com/news/growing-concern-over-the-administration-of-deeds 2017-07-18T16:03:01+10:00 https://pharmadispatch.com/news/new-trial-of-prostate-cancer-breakthrough 2017-07-18T16:01:01+10:00 https://pharmadispatch.com/news/fda-rejects-new-osteoporosis-biologic 2017-07-18T16:00:01+10:00 https://pharmadispatch.com/news/tga-approves-another-immunotherapy 2017-07-19T16:02:01+10:00 https://pharmadispatch.com/news/novartis-reports-improving-alcon-performance 2017-07-19T16:01:01+10:00 https://pharmadispatch.com/news/jj-raises-full-year-outlook 2017-07-19T16:00:01+10:00 https://pharmadispatch.com/news/government-will-be-rebating-the-rebates-but-not-with-interest 2017-07-19T16:03:01+10:00 https://pharmadispatch.com/news/new-hcv-therapy-for-pbs-in-august 2017-07-20T16:03:01+10:00 https://pharmadispatch.com/news/first-generics-of-popular-pain-therapy 2017-07-20T16:02:01+10:00 https://pharmadispatch.com/news/uniquest-seals-long-term-deal-to-tackle-diabetes-and-obesity-1 2017-07-20T16:00:01+10:00 https://pharmadispatch.com/news/quilty-whole-of-sector-challenge-1 2017-07-20T16:01:01+10:00 https://pharmadispatch.com/news/another-senior-official-leaves-pharmaceutical-benefits 2017-07-21T16:03:01+10:00 https://pharmadispatch.com/news/second-year-of-astellas-c3-prize 2017-07-21T16:01:01+10:00 https://pharmadispatch.com/news/tpp11-discussions-continue 2017-07-21T16:02:01+10:00 https://pharmadispatch.com/news/aft-secures-new-deal-for-maxigesic 2017-07-21T16:00:01+10:00 https://pharmadispatch.com/news/supply-chain-delivered-on-hcv 2017-07-24T16:03:01+10:00 https://pharmadispatch.com/news/americans-want-action-to-protect-innovation 2017-07-24T16:02:01+10:00 https://pharmadispatch.com/news/need-to-keep-pace-with-more-active-consumer 2017-07-24T16:01:01+10:00 https://pharmadispatch.com/news/more-cases-are-probably-coming 2017-07-25T04:04:01+10:00 https://pharmadispatch.com/news/msd-and-pfizer-back-trump-innovation-plan 2017-07-24T16:00:01+10:00 https://pharmadispatch.com/news/more-changes-on-deeds-and-rebates-likely 2017-07-25T16:02:01+10:00 https://pharmadispatch.com/news/were-adhering-to-deeds-says-department-of-health 2017-07-25T16:03:01+10:00 https://pharmadispatch.com/news/ndss-change-working-for-consumers 2017-07-25T16:00:01+10:00 https://pharmadispatch.com/news/guild-calls-for-codeine-exception 2017-07-25T16:01:01+10:00 https://pharmadispatch.com/news/a-meaningless-measure-in-the-era-of-rebates 2017-07-26T16:03:01+10:00 https://pharmadispatch.com/news/sector-gives-a-hand-for-ms 2017-07-26T16:01:01+10:00 https://pharmadispatch.com/news/pharmacy-loses-a-friend-in-cabinet 2017-07-26T16:02:01+10:00 https://pharmadispatch.com/news/better-than-expected-quarter-for-lilly 2017-07-26T16:00:01+10:00 https://pharmadispatch.com/news/ma-adopts-board-changes 2017-07-27T16:04:01+10:00 https://pharmadispatch.com/news/sigma-and-cw-move-to-resolve-supply-dispute 2017-07-27T16:03:01+10:00 https://pharmadispatch.com/news/psa-backs-ban-on-discounts-to-consumers 2017-07-27T16:02:01+10:00 https://pharmadispatch.com/news/new-products-lift-amgen 2017-07-27T16:00:01+10:00 https://pharmadispatch.com/news/leaders-out-of-step-with-public-opinion-on-reputation 2017-07-27T16:01:01+10:00 https://pharmadispatch.com/news/change-coming-for-ma 2017-07-27T16:05:01+10:00 https://pharmadispatch.com/news/diversity-essential-for-success-says-pfizers-melissa-mcgregor 2017-07-31T16:04:01+10:00 https://pharmadispatch.com/news/more-work-to-be-done 2017-07-28T16:00:01+10:00 https://pharmadispatch.com/news/research-institute-sells-rights-to-cancer-therapy 2017-07-28T16:02:01+10:00 https://pharmadispatch.com/news/dr-pimple-popper-welcomes-new-approval 2017-07-28T16:01:01+10:00 https://pharmadispatch.com/news/another-journey-to-the-heart-of-australia 2017-07-28T16:03:01+10:00 https://pharmadispatch.com/news/busy-day-for-astrazeneca 2017-07-28T16:04:01+10:00 https://pharmadispatch.com/news/statement-on-ma-ceo 2017-07-31T16:00:01+10:00 https://pharmadispatch.com/news/tga-unique-identifier-could-undermine-biosimilar-policy 2017-07-31T16:03:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-11bn-for-opdivo 2017-07-31T16:02:01+10:00 https://pharmadispatch.com/news/pharmacy-not-consulted-on-tax-request 2017-07-31T16:01:01+10:00 https://pharmadispatch.com/news/department-creates-new-division 2017-08-01T16:03:01+10:00 https://pharmadispatch.com/news/guild-slams-review-interim-report 2017-08-01T16:01:01+10:00 https://pharmadispatch.com/news/medicines-nz-2017-value-of-medicines-award 2017-08-01T16:00:01+10:00 https://pharmadispatch.com/news/agreement-an-opportunity-that-cant-be-lost 2017-08-01T16:02:01+10:00 https://pharmadispatch.com/news/review-needs-to-revisit-report 2017-08-02T16:02:01+10:00 https://pharmadispatch.com/news/professor-andrew-wilson-pbac-set-for-fundamental-change 2017-08-02T16:03:01+10:00 https://pharmadispatch.com/news/big-discounts-for-lyrica-generics 2017-08-02T16:01:01+10:00 https://pharmadispatch.com/news/pfizer-waiting-on-tax-changes-before-any-new-acquisitions 2017-08-02T16:00:01+10:00 https://pharmadispatch.com/news/who-has-been-guiding-this-review 2017-08-03T16:00:01+10:00 https://pharmadispatch.com/news/a-very-simple-solution-found-for-submission-cap 2017-08-03T16:00:01+10:00 https://pharmadispatch.com/news/review-recommendations-redundant 2017-08-03T16:00:01+10:00 https://pharmadispatch.com/news/does-this-reserve-actually-exist 2017-08-04T16:03:01+10:00 https://pharmadispatch.com/news/more-work-required-on-biosimilars 2017-08-04T16:02:01+10:00 https://pharmadispatch.com/news/sector-unites-to-slam-review 2017-08-04T16:01:01+10:00 https://pharmadispatch.com/news/global-award-for-pfizer-and-sudler-sydney 2017-08-04T16:00:01+10:00 https://pharmadispatch.com/news/first-deputy-chair-for-pbac 2017-08-07T16:00:01+10:00 https://pharmadispatch.com/news/full-committee-finally-in-place 2017-08-07T16:00:01+10:00 https://pharmadispatch.com/news/implications-of-change-remain-unclear 2017-08-07T16:00:01+10:00 https://pharmadispatch.com/news/a-need-to-be-consistent 2017-08-07T16:00:01+10:00 https://pharmadispatch.com/news/lsdp-review-outcome-still-with-government 2017-08-07T16:00:01+10:00 https://pharmadispatch.com/news/strong-support-for-pbac-deputy-chair 2017-08-08T16:00:01+10:00 https://pharmadispatch.com/news/all-eyes-on-second-brand-change-in-draft-legislation 2017-08-08T16:00:01+10:00 https://pharmadispatch.com/news/new-appointment-for-former-health-minister 2017-08-08T16:00:01+10:00 https://pharmadispatch.com/news/could-states-go-their-own-way-on-codeine 2017-08-08T16:00:01+10:00 https://pharmadispatch.com/news/mayne-update-falls-short-of-expectations 2017-08-09T16:01:01+10:00 https://pharmadispatch.com/news/retirement-for-senior-policy-maker 2017-08-09T16:04:01+10:00 https://pharmadispatch.com/news/time-to-act-says-rare-cancers 2017-08-09T16:02:01+10:00 https://pharmadispatch.com/news/sigma-slams-union-over-campaign-targeting-amcal 2017-08-09T16:00:01+10:00 https://pharmadispatch.com/news/guild-draws-battle-lines-over-ramsay 2017-08-09T16:03:01+10:00 https://pharmadispatch.com/news/minister-wants-new-process-for-pan-tumour-medicines 2017-08-09T19:38:01+10:00 https://pharmadispatch.com/news/companies-reflect-on-ramsay-distribution 2017-08-10T16:00:01+10:00 https://pharmadispatch.com/news/september-listing-for-gileads-zydelig 2017-08-10T16:00:01+10:00 https://pharmadispatch.com/news/labor-backs-pbac-process-change 2017-08-10T16:00:01+10:00 https://pharmadispatch.com/news/positive-trial-results-for-starpharmas-vivagel-bv 2017-08-10T16:00:01+10:00 https://pharmadispatch.com/news/gsks-anne-belcher-patients-benefit-when-the-relationship-works 2017-08-11T16:00:01+10:00 https://pharmadispatch.com/news/government-follows-bayer-with-commitment-to-heart-of-australia 2017-08-11T16:00:01+10:00 https://pharmadispatch.com/news/guild-ama-offensive-and-hypocritical 2017-08-11T16:00:01+10:00 https://pharmadispatch.com/news/tolmar-hosts-fourth-uro-oncology-symposium 2017-08-11T16:00:01+10:00 https://pharmadispatch.com/news/companies-back-same-sex-marriage 2017-08-14T16:00:01+10:00 https://pharmadispatch.com/news/timing-could-be-everything-on-new-price-cuts 2017-08-14T16:04:01+10:00 https://pharmadispatch.com/news/bi-backs-cv-research-with-grants 2017-08-14T16:01:01+10:00 https://pharmadispatch.com/news/ubs-downgrades-sigma-in-response-to-lower-forecast 2017-08-14T16:00:01+10:00 https://pharmadispatch.com/news/winning-one-part-of-the-drug-development-process 2017-08-14T16:02:01+10:00 https://pharmadispatch.com/news/review-carries-on-but-we-face-the-reality 2017-08-15T16:04:01+10:00 https://pharmadispatch.com/news/september-listing-for-new-pfizer-therapy 2017-08-15T16:03:01+10:00 https://pharmadispatch.com/news/perth-based-biotech-resurrects-cancer-therapy 2017-08-15T16:01:01+10:00 https://pharmadispatch.com/news/guild-what-about-doctor-shopping 2017-08-15T16:00:01+10:00 https://pharmadispatch.com/news/msd-boss-quits-trump-advisory-group 2017-08-15T16:02:01+10:00 https://pharmadispatch.com/news/a-big-week-for-industry-and-pbac 2017-08-16T16:03:01+10:00 https://pharmadispatch.com/news/new-publication-launches-tomorrow 2017-08-16T16:02:01+10:00 https://pharmadispatch.com/news/business-leaders-back-msds-frazier 2017-08-16T16:01:01+10:00 https://pharmadispatch.com/news/positive-study-results-for-opthea 2017-08-16T16:00:01+10:00 https://pharmadispatch.com/news/csl-hurt-by-high-expectations 2017-08-17T16:02:01+10:00 https://pharmadispatch.com/news/response-to-ip-report-moving-closer 2017-08-17T16:03:01+10:00 https://pharmadispatch.com/news/jj-ceo-resigns-from-trump-advisory-group 2017-08-17T16:01:01+10:00 https://pharmadispatch.com/news/msd-partnership-boosts-bionomics 2017-08-17T16:00:01+10:00 https://pharmadispatch.com/news/overdiagnosis-of-overdiagnosis 2017-08-18T16:00:01+10:00 https://pharmadispatch.com/news/gbma-will-invite-ma-to-biosimilar-discussions 2017-08-18T16:00:01+10:00 https://pharmadispatch.com/news/an-invitation-to-engage-in-unlawful-conduct 2017-08-18T16:00:01+10:00 https://pharmadispatch.com/news/new-ceo-for-blackmores 2017-08-18T16:00:01+10:00 https://pharmadispatch.com/news/timing-means-nothing-has-really-changed 2017-08-21T16:04:01+10:00 https://pharmadispatch.com/news/outcomes-reveal-carnage-at-july-pbac 2017-08-21T16:05:01+10:00 https://pharmadispatch.com/news/pbac-says-no-to-tighter-prescribing 2017-08-21T16:03:01+10:00 https://pharmadispatch.com/news/was-that-such-a-good-idea 2017-08-21T16:06:01+10:00 https://pharmadispatch.com/news/nz-candidates-agree-on-access-issues 2017-08-21T16:01:01+10:00 https://pharmadispatch.com/news/calls-for-depression-study-participants 2017-08-21T16:00:01+10:00 https://pharmadispatch.com/news/labor-wants-action-on-prep 2017-08-21T16:02:01+10:00 https://pharmadispatch.com/news/sector-reviewing-draft-legislation 2017-08-22T16:03:01+10:00 https://pharmadispatch.com/news/is-that-really-evidence-based 2017-08-22T16:02:01+10:00 https://pharmadispatch.com/news/pharmaxis-welcomes-pbs-recommendation 2017-08-22T16:01:01+10:00 https://pharmadispatch.com/news/monash-biomedicine-discovery-institute-joins-mrcf 2017-08-22T16:00:01+10:00 https://pharmadispatch.com/news/large-field-for-ma-board-election 2017-08-23T15:00:01+10:00 https://pharmadispatch.com/news/martin-bowles-resigns 2017-08-23T01:53:01+10:00 https://pharmadispatch.com/news/new-australian-partnership-for-janssen 2017-08-23T16:00:01+10:00 https://pharmadispatch.com/news/sector-tribute-to-martin-bowles 2017-08-23T16:00:01+10:00 https://pharmadispatch.com/news/mp-roundtable-in-melbourne-today 2017-08-23T16:00:01+10:00 https://pharmadispatch.com/news/one-of-the-least-surprising-announcements 2017-08-23T16:00:01+10:00 https://pharmadispatch.com/news/health-adviser-leaves-turnbull-staff 2017-08-24T16:03:01+10:00 https://pharmadispatch.com/news/switch-from-any-bdmard 2017-08-24T16:02:01+10:00 https://pharmadispatch.com/news/complex-agenda-for-november-pbac 2017-08-24T16:01:01+10:00 https://pharmadispatch.com/news/industry-dominates-ato-audits 2017-08-24T16:00:01+10:00 https://pharmadispatch.com/news/ebos-earnings-rise-despite-pbs-reform-impact 2017-08-25T16:00:01+10:00 https://pharmadispatch.com/news/new-research-funding 2017-08-25T16:00:01+10:00 https://pharmadispatch.com/news/novartis-appoints-retail-expert-to-global-digital-role 2017-08-25T16:00:01+10:00 https://pharmadispatch.com/news/study-highlights-long-term-benefits-of-brilinta 2017-08-25T16:00:01+10:00 https://pharmadispatch.com/news/new-boss-for-az-australia 2017-08-25T16:07:01+10:00 https://pharmadispatch.com/news/ip-response-a-virtual-slam-dunk-on-key-issues 2017-08-28T16:05:01+10:00 https://pharmadispatch.com/news/bi-progresses-pharmaxis-therapy 2017-08-28T16:01:01+10:00 https://pharmadispatch.com/news/pay-for-delay-reporting-extraordinary 2017-08-28T16:02:01+10:00 https://pharmadispatch.com/news/governments-ip-response-the-detail 2017-08-28T16:04:01+10:00 https://pharmadispatch.com/news/reporting-copies-us-arrangement 2017-08-28T16:03:01+10:00 https://pharmadispatch.com/news/new-study-boosts-bayers-xarelto 2017-08-28T16:00:01+10:00 https://pharmadispatch.com/news/australian-patients-lag-on-lung-cancer 2017-08-29T16:04:01+10:00 https://pharmadispatch.com/news/csl-acquires-gene-therapy-company 2017-08-29T16:02:01+10:00 https://pharmadispatch.com/news/api-withdraws-from-acquisition-process 2017-08-29T16:01:01+10:00 https://pharmadispatch.com/news/pradaxa-tops-warfarin-in-safety-trial 2017-08-29T16:00:01+10:00 https://pharmadispatch.com/news/gbma-backs-ip-response 2017-08-29T16:03:01+10:00 https://pharmadispatch.com/news/new-leadership-for-celgene 2017-08-30T16:00:01+10:00 https://pharmadispatch.com/news/more-nominations-for-ma-board 2017-08-30T16:00:01+10:00 https://pharmadispatch.com/news/janssen-welcomes-wider-stelara-listing 2017-08-30T16:00:01+10:00 https://pharmadispatch.com/news/china-hits-blackmores-result 2017-08-30T16:00:01+10:00 https://pharmadispatch.com/news/gsk-opens-shopper-science-lab 2017-08-31T16:00:01+10:00 https://pharmadispatch.com/news/department-appoints-acting-deputy-secretary 2017-08-31T16:00:01+10:00 https://pharmadispatch.com/news/gilead-hoping-for-another-pharmasset 2017-08-30T16:00:01+10:00 https://pharmadispatch.com/news/changes-make-for-an-unpredictable-outcome 2017-08-31T16:00:01+10:00 https://pharmadispatch.com/news/first-pbs-treatment-for-disabling-skin-condition 2017-08-31T16:00:01+10:00 https://pharmadispatch.com/news/paradigm-shift-required-for-personalised-medicine 2017-09-01T16:00:01+10:00 https://pharmadispatch.com/news/ramsay-pushing-pharmacy-expansion 2017-09-01T16:00:01+10:00 https://pharmadispatch.com/news/arrow-and-juno-split-amneal-business 2017-09-01T16:00:01+10:00 https://pharmadispatch.com/news/mixed-exposure-for-draft-legislation 2017-09-01T16:00:01+10:00 https://pharmadispatch.com/news/another-confirmed-candidate-for-ma-election 2017-09-01T16:00:01+10:00 https://pharmadispatch.com/news/tpp-countries-scrap-pharma-ip-provisions 2017-09-04T16:00:01+10:00 https://pharmadispatch.com/news/paying-the-price-for-a-ridiculous-charade 2017-09-04T16:00:01+10:00 https://pharmadispatch.com/news/funding-for-pharmacy-codeine-training 2017-09-04T16:00:01+10:00 https://pharmadispatch.com/news/changes-at-sigma 2017-09-04T16:00:01+10:00 https://pharmadispatch.com/news/us-go-ahead-for-adheriums-symbicort-platform 2017-09-04T16:00:01+10:00 https://pharmadispatch.com/news/new-health-adviser-for-turnbull 2017-09-05T16:00:01+10:00 https://pharmadispatch.com/news/new-report-calls-for-action-on-hiv 2017-09-05T16:00:01+10:00 https://pharmadispatch.com/news/taking-it-to-the-hill 2017-09-05T16:00:01+10:00 https://pharmadispatch.com/news/new-global-leadership-for-novartis 2017-09-05T16:00:01+10:00 https://pharmadispatch.com/news/juno-joins-gbma 2017-09-05T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-health 2017-09-06T16:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-delivers-a-very-direct-message 2017-09-05T22:09:01+10:00 https://pharmadispatch.com/news/sometimes-just-getting-together-is-enough 2017-09-06T16:00:01+10:00 https://pharmadispatch.com/news/new-partnership-to-tackle-cancer-and-alzheimers-disease 2017-09-06T16:00:01+10:00 https://pharmadispatch.com/news/new-trial-for-imugenes-her-vaxx-immunotherapy 2017-09-06T16:00:01+10:00 https://pharmadispatch.com/news/the-deepening-mystery-of-savings-fund 2017-09-07T16:00:01+10:00 https://pharmadispatch.com/news/chf-says-no-to-industry 2017-09-07T16:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-progresses-loxl2-inhibitor 2017-09-07T16:00:01+10:00 https://pharmadispatch.com/news/who-was-listening 2017-09-07T16:00:01+10:00 https://pharmadispatch.com/news/sigma-acquires-dose-administration-leader 2017-09-08T16:00:01+10:00 https://pharmadispatch.com/news/higher-pbac-fees-could-win-industry-support 2017-09-08T16:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-new-appointments 2017-09-08T16:00:01+10:00 https://pharmadispatch.com/news/sector-backs-legislation 2017-09-08T16:00:01+10:00 https://pharmadispatch.com/news/brian-gladsden-time-to-take-on-our-critics 2017-09-11T16:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-set-to-trigger-another-milestone 2017-09-11T16:00:01+10:00 https://pharmadispatch.com/news/companies-showcase-new-therapies-at-esmo 2017-09-11T16:00:01+10:00 https://pharmadispatch.com/news/mental-health-and-new-brands-headline-october-pbs 2017-09-11T16:00:01+10:00 https://pharmadispatch.com/news/wholesalers-want-strategic-agreement 2017-09-11T16:00:01+10:00 https://pharmadispatch.com/news/step-towards-a-single-agreement 2017-09-12T16:00:01+10:00 https://pharmadispatch.com/news/new-portal-supporting-medicinal-cannabis 2017-09-12T16:00:01+10:00 https://pharmadispatch.com/news/opdivo-shines-in-australian-trial 2017-09-12T16:00:01+10:00 https://pharmadispatch.com/news/voting-underway-in-ma-board-election 2017-09-12T16:00:01+10:00 https://pharmadispatch.com/news/new-indication-for-msds-keytruda 2017-09-12T16:00:01+10:00 https://pharmadispatch.com/news/delay-to-avoid-unintended-consequences-or-misinterpretations 2017-09-13T16:00:01+10:00 https://pharmadispatch.com/news/amgen-launches-education-initiative-in-australia 2017-09-13T16:00:01+10:00 https://pharmadispatch.com/news/salary-survey-reveals-the-latest-on-industry 2017-09-13T16:00:01+10:00 https://pharmadispatch.com/news/tga-annual-performance-report 2017-09-13T16:00:01+10:00 https://pharmadispatch.com/news/maestro-going-global 2017-09-14T16:00:01+10:00 https://pharmadispatch.com/news/ma-board-candidates-put-their-case 2017-09-14T16:00:01+10:00 https://pharmadispatch.com/news/keytruda-triple-combination-delivers-in-lung 2017-09-14T16:00:01+10:00 https://pharmadispatch.com/news/immunisation-incentive-payment-working 2017-09-14T16:00:01+10:00 https://pharmadispatch.com/news/ip-australia-consulting-on-government-response-to-pbs-report 2017-09-15T16:00:01+10:00 https://pharmadispatch.com/news/the-work-starts-now-says-takedas-james-jones 2017-09-15T16:00:01+10:00 https://pharmadispatch.com/news/who-sits-in-judgement-of-industry 2017-09-15T16:00:01+10:00 https://pharmadispatch.com/news/fda-approves-first-avastin-biosimilar 2017-09-15T16:00:01+10:00 https://pharmadispatch.com/news/ipsens-peter-koetsier-an-opportunity-too-good-to-miss 2017-09-17T16:00:01+10:00 https://pharmadispatch.com/news/someone-must-have-listened 2017-09-18T16:00:01+10:00 https://pharmadispatch.com/news/health-a-focus-as-nz-election-remains-too-close-to-call 2017-09-18T16:00:01+10:00 https://pharmadispatch.com/news/reform-on-top-of-reform 2017-09-18T16:00:01+10:00 https://pharmadispatch.com/news/rescheduling-decisions-on-key-medicines 2017-09-18T16:00:01+10:00 https://pharmadispatch.com/news/sector-battles-it-our-over-biologic-naming 2017-09-19T16:00:01+10:00 https://pharmadispatch.com/news/first-day-on-the-job-for-new-secretaries 2017-09-19T16:00:01+10:00 https://pharmadispatch.com/news/government-backs-world-first-trial-in-childhood-cancers 2017-09-19T16:00:01+10:00 https://pharmadispatch.com/news/new-zealand-set-to-fund-shingles-vaccine 2017-09-19T16:00:01+10:00 https://pharmadispatch.com/news/a-shortish-history-the-name-game 2017-09-20T16:00:01+10:00 https://pharmadispatch.com/news/msd-backs-european-naming-system 2017-09-20T16:00:01+10:00 https://pharmadispatch.com/news/a-new-industry-and-innovation-minister 2017-09-20T16:00:01+10:00 https://pharmadispatch.com/news/new-mou-for-mtpconnect 2017-09-20T16:00:01+10:00 https://pharmadispatch.com/news/cholesterol-biologics-show-benefit-for-diabetics 2017-09-21T16:00:01+10:00 https://pharmadispatch.com/news/massive-saving-but-not-very-feasible 2017-09-21T16:00:01+10:00 https://pharmadispatch.com/news/why-not-the-who-model 2017-09-21T16:00:01+10:00 https://pharmadispatch.com/news/survey-reveals-extent-of-medicine-use 2017-09-21T16:00:01+10:00 https://pharmadispatch.com/news/minister-confirms-interest-in-agreement-with-wholesalers 2017-09-22T16:00:01+10:00 https://pharmadispatch.com/news/pfizer-sues-jj-over-biosimilar-exclusion-contracts 2017-09-22T16:00:01+10:00 https://pharmadispatch.com/news/ferris-australia-falling-behind 2017-09-22T16:00:01+10:00 https://pharmadispatch.com/news/consumers-unhappy-over-codeine 2017-09-22T16:00:01+10:00 https://pharmadispatch.com/news/european-approval-for-new-pd-l1-antibody 2017-09-22T16:00:01+10:00 https://pharmadispatch.com/news/second-order-issues-distract-from-whats-important 2017-09-25T16:00:01+10:00 https://pharmadispatch.com/news/nz-kingmaker-wants-pharmac-review 2017-09-25T16:00:01+10:00 https://pharmadispatch.com/news/medicines-a-factor-in-massive-decline-in-cv-deaths 2017-09-25T16:00:01+10:00 https://pharmadispatch.com/news/bcna-review-pbs-to-address-financial-burden 2017-09-25T16:00:01+10:00 https://pharmadispatch.com/news/clinical-trials-system-broken 2017-09-25T16:00:01+10:00 https://pharmadispatch.com/news/us-clearing-path-for-cell-therapies 2017-09-26T16:00:01+10:00 https://pharmadispatch.com/news/groups-call-for-action-on-opioids 2017-09-26T16:00:01+10:00 https://pharmadispatch.com/news/abbvie-steps-up-on-marriage-equality 2017-09-26T16:00:01+10:00 https://pharmadispatch.com/news/more-work-needed-on-contraception 2017-09-26T16:00:01+10:00 https://pharmadispatch.com/news/spike-in-rebates-offsets-pbs-growth 2017-09-26T21:17:01+10:00 https://pharmadispatch.com/news/more-from-rebates-than-taxes-on-beer 2017-09-27T16:00:01+10:00 https://pharmadispatch.com/news/sometimes-answers-just-make-no-sense 2017-09-27T16:00:01+10:00 https://pharmadispatch.com/news/cost-recovery-changes-coming 2017-09-27T16:00:01+10:00 https://pharmadispatch.com/news/vaccines-for-parallel-process 2017-09-27T16:00:01+10:00 https://pharmadispatch.com/news/ma-industry-sacrifices-deliver-for-pbs 2017-09-27T16:00:01+10:00 https://pharmadispatch.com/news/amgen-backs-us-naming-system 2017-09-28T16:00:01+10:00 https://pharmadispatch.com/news/its-time-to-tell-our-story 2017-09-28T16:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-hps 2017-09-28T16:00:01+10:00 https://pharmadispatch.com/news/doubling-down-on-the-ridiculousness 2017-09-28T16:00:01+10:00 https://pharmadispatch.com/news/have-your-say-on-digital-transformation-and-multi-channel-market 2017-09-28T16:00:01+10:00 https://pharmadispatch.com/news/more-agreements-coming-for-health-sector 2017-09-29T16:00:01+10:00 https://pharmadispatch.com/news/msd-hoping-for-stakeholder-support 2017-09-29T16:00:01+10:00 https://pharmadispatch.com/news/will-clones-qualify-for-uptake-drivers 2017-09-29T16:00:01+10:00 https://pharmadispatch.com/news/new-indication-boost-for-novartis-copd-therapy 2017-09-29T16:00:01+10:00 https://pharmadispatch.com/news/abbvie-teams-up-with-guild-and-secures-global-agreement-on-humir 2017-09-29T16:00:01+10:00 https://pharmadispatch.com/news/industry-a-big-winner-from-trump-tax-proposal 2017-10-03T17:00:01+11:00 https://pharmadispatch.com/news/new-schizophrenia-therapy-welcomed 2017-10-03T17:00:01+11:00 https://pharmadispatch.com/news/price-cut-probably-beats-a-post-market-review 2017-10-03T17:00:01+11:00 https://pharmadispatch.com/news/everyone-wants-to-rewrite-history 2017-10-03T17:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-to-decide-on-first-uptake-driver 2017-10-03T17:00:01+11:00 https://pharmadispatch.com/news/exclusive-thousands-could-benefit-from-new-pbs-process 2017-10-04T17:00:01+11:00 https://pharmadispatch.com/news/a-busy-year-for-ausbiotech 2017-10-04T17:00:01+11:00 https://pharmadispatch.com/news/industry-backs-macquarie-scholarship-program 2017-10-04T17:00:01+11:00 https://pharmadispatch.com/news/terrywhite-chemmart-teams-up-with-heart-foundation 2017-10-04T17:00:01+11:00 https://pharmadispatch.com/news/dismayed-and-frustrated-over-fifth-rejection 2017-10-05T17:00:01+11:00 https://pharmadispatch.com/news/companies-would-utilise-the-process 2017-10-05T17:00:01+11:00 https://pharmadispatch.com/news/pbac-process-facing-major-overhaul 2017-10-05T17:00:01+11:00 https://pharmadispatch.com/news/az-celebrates-60-years-in-australia 2017-10-05T17:00:01+11:00 https://pharmadispatch.com/news/december-agenda-confirms-the-postponed-six 2017-10-05T17:00:01+11:00 https://pharmadispatch.com/news/cancer-researcher-wins-gsk-award 2017-10-06T17:00:01+11:00 https://pharmadispatch.com/news/real-world-study-delivers-for-gsks-breo-ellipta 2017-10-05T22:25:01+11:00 https://pharmadispatch.com/news/merck-fellowship-in-gastro-intestinal-research 2017-10-06T17:00:01+11:00 https://pharmadispatch.com/news/carers-suffering-without-support 2017-10-06T17:00:01+11:00 https://pharmadispatch.com/news/another-460m-for-janssens-imbruvica 2017-10-09T17:00:01+11:00 https://pharmadispatch.com/news/pbac-to-extend-biosimilar-default 2017-10-09T17:00:01+11:00 https://pharmadispatch.com/news/novartis-argues-for-eu-naming-convention 2017-10-09T17:00:01+11:00 https://pharmadispatch.com/news/cda-shuts-down-but-not-without-leaving-a-legacy 2017-10-08T22:37:01+11:00 https://pharmadispatch.com/news/codeine-debate-goes-on 2017-10-09T17:00:01+11:00 https://pharmadispatch.com/news/upgraded-hpv-vaccine-for-nip 2017-10-09T17:00:01+11:00 https://pharmadispatch.com/news/one-pager-rules-special-pricing-arrangements 2017-10-10T17:00:01+11:00 https://pharmadispatch.com/news/a-consultation-clause-is-not-a-no-savings-clause 2017-10-10T17:00:01+11:00 https://pharmadispatch.com/news/pm-the-best-part-of-the-job 2017-10-10T17:00:01+11:00 https://pharmadispatch.com/news/amneal-brands-start-coming-off-pbs 2017-10-10T17:00:01+11:00 https://pharmadispatch.com/news/contract-win-for-sigma 2017-10-11T17:00:01+11:00 https://pharmadispatch.com/news/there-are-rules-and-there-are-rules 2017-10-11T17:00:01+11:00 https://pharmadispatch.com/news/transparency-and-efficiency-on-the-agenda 2017-10-11T17:00:01+11:00 https://pharmadispatch.com/news/pfizer-considering-sale-of-consumer-health-business 2017-10-11T17:00:01+11:00 https://pharmadispatch.com/news/when-not-mandatory-is-actually-mandatory 2017-10-12T17:00:01+11:00 https://pharmadispatch.com/news/reference-brands-rather-than-reference-biologics 2017-10-12T17:00:01+11:00 https://pharmadispatch.com/news/government-funded-flu-vax-the-next-step 2017-10-12T17:00:01+11:00 https://pharmadispatch.com/news/canteen-trial-funding-as-part-of-new-200m-research-round 2017-10-13T05:00:01+11:00 https://pharmadispatch.com/news/its-all-about-change-says-abbvies-kirsten-odoherty 2017-10-13T17:00:01+11:00 https://pharmadispatch.com/news/working-life-at-abbvie 2017-10-13T17:00:01+11:00 https://pharmadispatch.com/news/revealed-uptake-driver-implementation-plan 2017-10-13T17:00:01+11:00 https://pharmadispatch.com/news/nobody-will-want-to-be-health-minister-in-2022 2017-10-16T17:00:01+11:00 https://pharmadispatch.com/news/novartis-to-retain-roche-stake 2017-10-13T17:00:01+11:00 https://pharmadispatch.com/news/new-funding-for-israeli-australian-company 2017-10-13T17:00:01+11:00 https://pharmadispatch.com/news/us-delegation-in-australia-for-ip-talks 2017-10-16T17:00:01+11:00 https://pharmadispatch.com/news/reforms-required-as-patients-miss-out 2017-10-16T17:00:01+11:00 https://pharmadispatch.com/news/from-three-to-two-meetings 2017-10-17T17:00:01+11:00 https://pharmadispatch.com/news/the-end-arrives-for-cetp-inhibitors 2017-10-16T17:00:01+11:00 https://pharmadispatch.com/news/department-delays-biosimilar-implementation-plans 2017-10-16T17:00:01+11:00 https://pharmadispatch.com/news/pbs-changes-could-be-in-parliament-this-week 2017-10-17T17:00:01+11:00 https://pharmadispatch.com/news/csl-fellowships-target-cancer-and-cardiovascular-disease 2017-10-17T17:00:01+11:00 https://pharmadispatch.com/news/new-name-for-evolving-novogen 2017-10-17T17:00:01+11:00 https://pharmadispatch.com/news/positive-results-for-bms-immunotherapy-combination-in-lung-cance 2017-10-17T17:00:01+11:00 https://pharmadispatch.com/news/who-officially-scraps-proposed-naming-convention 2017-10-18T17:00:01+11:00 https://pharmadispatch.com/news/tributes-for-levinia-crooks-am 2017-10-18T17:00:01+11:00 https://pharmadispatch.com/news/viiv-announces-positive-action-community-grants 2017-10-18T17:00:01+11:00 https://pharmadispatch.com/news/settlement-for-sigma-and-chemist-warehouse 2017-10-18T17:00:01+11:00 https://pharmadispatch.com/news/urgent-action-required-on-the-greatest-epidemic 2017-10-18T17:00:01+11:00 https://pharmadispatch.com/news/an-exception-or-new-paradigm-time-will-tell 2017-10-19T17:00:01+11:00 https://pharmadispatch.com/news/jj-fighting-off-biosimilars-in-the-us 2017-10-19T17:00:01+11:00 https://pharmadispatch.com/news/bill-introduced-but-questions-remain 2017-10-19T17:00:01+11:00 https://pharmadispatch.com/news/ministerial-roundtable-on-bone-health 2017-10-19T17:00:01+11:00 https://pharmadispatch.com/news/industry-association-looking-for-new-leader 2017-10-20T05:00:01+11:00 https://pharmadispatch.com/news/stem-partnership-between-sanofi-and-the-smith-family 2017-10-20T17:00:01+11:00 https://pharmadispatch.com/news/keytruda-holds-survival-gains 2017-10-20T17:00:01+11:00 https://pharmadispatch.com/news/pharmacists-say-doctors-blocking-scheduling-reform 2017-10-20T17:00:01+11:00 https://pharmadispatch.com/news/policy-block-to-reverse-substitution 2017-10-20T17:00:01+11:00 https://pharmadispatch.com/news/new-government-could-mean-change-for-pharmac 2017-10-20T17:00:01+11:00 https://pharmadispatch.com/news/solid-year-for-api-in-the-face-of-tough-conditions 2017-10-20T17:00:01+11:00 https://pharmadispatch.com/news/ara-more-clarity-required-on-uptake-drivers 2017-10-23T17:00:01+11:00 https://pharmadispatch.com/news/uptake-driver-will-not-work-for-acute-treatments 2017-10-23T17:00:01+11:00 https://pharmadispatch.com/news/patients-paying-the-price-of-under-treatment 2017-10-23T17:00:01+11:00 https://pharmadispatch.com/news/us-delegation-stands-ground-on-ip 2017-10-23T17:00:01+11:00 https://pharmadispatch.com/news/participants-gather-for-bridge-program-conference 2017-10-23T17:00:01+11:00 https://pharmadispatch.com/news/government-needs-to-back-medicines-on-prevention 2017-10-23T17:00:01+11:00 https://pharmadispatch.com/news/uptake-improves-or-price-cuts-coming 2017-10-24T17:00:01+11:00 https://pharmadispatch.com/news/innovation-the-focus-at-healthy-ageing-conference 2017-10-24T17:00:01+11:00 https://pharmadispatch.com/news/key-figure-retiring-just-as-things-get-interesting 2017-10-24T17:00:01+11:00 https://pharmadispatch.com/news/biointelect-appoints-ex-lilly-market-access-head 2017-10-24T17:00:01+11:00 https://pharmadispatch.com/news/gender-realignment-for-ma-board 2017-10-25T17:00:01+11:00 https://pharmadispatch.com/news/productivity-commission-delivers-pharmacy-a-gift 2017-10-25T17:00:01+11:00 https://pharmadispatch.com/news/biggest-biotech-ipo-since-csl 2017-10-25T17:00:01+11:00 https://pharmadispatch.com/news/wa-to-protect-pharmacy-integrity 2017-10-25T17:00:01+11:00 https://pharmadispatch.com/news/novartis-pushing-on-alcon 2017-10-25T17:00:01+11:00 https://pharmadispatch.com/news/ebos-takes-strategic-stake-in-medadvisor 2017-10-25T17:00:01+11:00 https://pharmadispatch.com/news/encouraged-rather-than-preferred 2017-10-26T17:00:01+11:00 https://pharmadispatch.com/news/australians-blame-lung-cancer-victims 2017-10-26T17:00:01+11:00 https://pharmadispatch.com/news/new-medicines-australia-board 2017-10-27T02:30:01+11:00 https://pharmadispatch.com/news/low-uptake-hits-online-authorities 2017-10-26T17:00:01+11:00 https://pharmadispatch.com/news/new-health-minister-for-nz 2017-10-26T17:00:01+11:00 https://pharmadispatch.com/news/msd-signs-collaboration-with-uniquest 2017-10-26T17:00:01+11:00 https://pharmadispatch.com/news/ma-boards-new-faces 2017-10-26T17:00:01+11:00 https://pharmadispatch.com/news/things-get-heated-at-senate-estimates 2017-10-26T22:37:01+11:00 https://pharmadispatch.com/news/snapshot-shows-magnitude-of-life-sciences-sector 2017-10-27T17:00:01+11:00 https://pharmadispatch.com/news/new-projects-funded-by-mtpconnect 2017-10-27T17:00:01+11:00 https://pharmadispatch.com/news/new-branding-for-medicines-australia 2017-10-27T17:00:01+11:00 https://pharmadispatch.com/news/opdivo-delivering-for-bms 2017-10-27T17:00:01+11:00 https://pharmadispatch.com/news/another-ip-test-for-australia 2017-10-30T17:00:01+11:00 https://pharmadispatch.com/news/extension-study-key-for-orkambi-listing 2017-10-30T17:00:01+11:00 https://pharmadispatch.com/news/pbac-unhappy-on-humira-but-timing-vindicates-abbvie 2017-10-30T17:00:01+11:00 https://pharmadispatch.com/news/pbac-says-no-to-price-cut-conditions 2017-10-30T17:00:01+11:00 https://pharmadispatch.com/news/clinicians-welcome-darzalex-approval 2017-10-30T17:00:01+11:00 https://pharmadispatch.com/news/wholesalers-and-pharmacy-want-action-on-direct-distribution 2017-10-30T17:00:01+11:00 https://pharmadispatch.com/news/no-end-in-sight-to-slow-uptake 2017-11-01T17:00:01+11:00 https://pharmadispatch.com/news/discretion-could-be-the-most-dangerous-word 2017-11-01T17:00:01+11:00 https://pharmadispatch.com/news/investors-react-on-direct-distribution 2017-10-31T17:00:01+11:00 https://pharmadispatch.com/news/33-billion-anyone 2017-10-31T17:00:01+11:00 https://pharmadispatch.com/news/cmo-slams-cheap-flux-vax-claims 2017-10-31T17:00:01+11:00 https://pharmadispatch.com/news/lsdp-announcement-imminent 2017-10-31T17:00:01+11:00 https://pharmadispatch.com/news/anao-raised-concerns-over-administration-of-deeds 2017-11-01T17:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-jj-innovation-industry-excellence-awards-1 2017-11-01T17:00:01+11:00 https://pharmadispatch.com/news/medicare-funding-for-cancer-gene-test 2017-11-02T06:00:01+11:00 https://pharmadispatch.com/news/can-both-numbers-be-right 2017-11-02T17:00:01+11:00 https://pharmadispatch.com/news/mixed-news-for-astrazeneca 2017-11-02T17:00:01+11:00 https://pharmadispatch.com/news/government-building-mrff-grants 2017-11-02T17:00:01+11:00 https://pharmadispatch.com/news/madness-not-to-invest-in-government-relations 2017-11-03T17:00:01+11:00 https://pharmadispatch.com/news/government-too-conservative-on-otc-switch 2017-11-03T17:00:01+11:00 https://pharmadispatch.com/news/tga-approval-for-novartis-kisqali 2017-11-03T17:00:01+11:00 https://pharmadispatch.com/news/australians-too-relaxed-about-antibiotic-resistance 2017-11-03T17:00:01+11:00 https://pharmadispatch.com/news/rebate-response-reveals-the-facts 2017-11-06T17:00:01+11:00 https://pharmadispatch.com/news/rebate-clarity-goes-close-to-revealing-real-hcv-price 2017-11-06T17:00:01+11:00 https://pharmadispatch.com/news/biogen-welcomes-approval-of-australian-first-treatment 2017-11-06T17:00:01+11:00 https://pharmadispatch.com/news/turnbull-and-ardern-back-tpp-11 2017-11-06T17:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-codeine-implementation-a-matter-for-states 2017-11-06T17:00:01+11:00 https://pharmadispatch.com/news/pbac-says-no-to-lifting-bdmard-criteria 2017-11-06T17:00:01+11:00 https://pharmadispatch.com/news/nps-issues-annual-report 2017-11-06T17:00:01+11:00 https://pharmadispatch.com/news/slowing-hcv-uptake-a-concern 2017-11-07T17:00:01+11:00 https://pharmadispatch.com/news/venturewise-growing-slowly 2017-11-07T17:00:01+11:00 https://pharmadispatch.com/news/vertex-reports-positive-results-from-another-cf-combination 2017-11-07T17:00:01+11:00 https://pharmadispatch.com/news/government-set-to-table-response-to-senate-cancer-inquiry 2017-11-07T17:00:01+11:00 https://pharmadispatch.com/news/labor-wants-action-on-meningococcal-b 2017-11-07T17:00:01+11:00 https://pharmadispatch.com/news/top-10-not-what-it-used-it-be 2017-11-08T17:00:01+11:00 https://pharmadispatch.com/news/new-name-for-quintilesims 2017-11-08T17:00:01+11:00 https://pharmadispatch.com/news/amgen-veteran-joins-actinogen 2017-11-08T17:00:01+11:00 https://pharmadispatch.com/news/telephony-report-shows-extent-on-pbs-authorities 2017-11-08T17:00:01+11:00 https://pharmadispatch.com/news/change-needed-or-it-just-gets-worse 2017-11-09T17:00:01+11:00 https://pharmadispatch.com/news/the-biggest-problem-is-us-guys-we-are-the-problem 2017-11-14T17:00:01+11:00 https://pharmadispatch.com/news/digital-strategy-a-missed-opportunity 2017-11-09T17:00:01+11:00 https://pharmadispatch.com/news/former-health-minister-appointed-to-key-health-post 2017-11-09T17:00:01+11:00 https://pharmadispatch.com/news/another-restructure-coming-for-health 2017-11-09T17:00:01+11:00 https://pharmadispatch.com/news/sanofi-genzyme-joins-captains-ride-for-rare-disease 2017-11-09T19:57:01+11:00 https://pharmadispatch.com/news/discussions-continue-on-mandatory-reporting 2017-11-10T17:00:01+11:00 https://pharmadispatch.com/news/pbs-schedule-update-delayed 2017-11-10T17:00:01+11:00 https://pharmadispatch.com/news/government-confident-reforms-get-through-before-year-end 2017-11-10T17:00:01+11:00 https://pharmadispatch.com/news/ceo-resigns-from-pharmaceutical-society-of-australia 2017-11-10T17:00:01+11:00 https://pharmadispatch.com/news/uptake-drivers-for-brenzys-in-december 2017-11-13T17:00:01+11:00 https://pharmadispatch.com/news/by-election-for-industrys-strongest-supporter 2017-11-13T17:00:01+11:00 https://pharmadispatch.com/news/perceptions-matter-for-ma 2017-11-13T17:00:01+11:00 https://pharmadispatch.com/news/simply-wrong-or-wilfully-misleading-on-ip 2017-11-13T17:00:01+11:00 https://pharmadispatch.com/news/new-documents-reveal-more-on-key-decisions 2017-11-13T17:00:01+11:00 https://pharmadispatch.com/news/international-comparisons-not-so-easy 2017-11-14T17:00:01+11:00 https://pharmadispatch.com/news/ex-gsk-executive-new-senate-president 2017-11-14T17:00:01+11:00 https://pharmadispatch.com/news/medicines-nz-seeking-new-chair 2017-11-14T17:00:01+11:00 https://pharmadispatch.com/news/australian-developed-testosterone-treatment-coming-off-the-pbs 2017-11-14T17:00:01+11:00 https://pharmadispatch.com/news/is-that-really-a-minor-or-administrative-change 2017-11-15T17:00:01+11:00 https://pharmadispatch.com/news/new-chief-executive-for-pharmac 2017-11-15T17:00:01+11:00 https://pharmadispatch.com/news/mandatory-reporting-on-mpa-agenda 2017-11-15T17:00:01+11:00 https://pharmadispatch.com/news/ramsay-acquires-queensland-pharmacy-chain 2017-11-15T17:00:01+11:00 https://pharmadispatch.com/news/new-venture-for-ex-ma-chief-executive 2017-11-16T17:00:01+11:00 https://pharmadispatch.com/news/companies-welcome-survey-result 2017-11-16T17:00:01+11:00 https://pharmadispatch.com/news/chf-working-on-its-own-financial-sustainability 2017-11-16T17:00:01+11:00 https://pharmadispatch.com/news/us-tax-cut-could-hit-advanced-manufacturing 2017-11-16T17:00:01+11:00 https://pharmadispatch.com/news/biosimilars-remain-centre-stage 2017-11-16T17:00:01+11:00 https://pharmadispatch.com/news/pharmacy-lags-natural-therapies 2017-11-17T17:00:01+11:00 https://pharmadispatch.com/news/departmental-restructure-underway 2017-11-17T17:00:01+11:00 https://pharmadispatch.com/news/sydney-based-biotron-reports-positive-results-from-hbv-studies 2017-11-17T17:00:01+11:00 https://pharmadispatch.com/news/dendright-advances-immunotherapy 2017-11-17T17:00:01+11:00 https://pharmadispatch.com/news/pbs-leadership-takes-shape 2017-11-20T17:00:01+11:00 https://pharmadispatch.com/news/action-required-on-falling-treatment-rates 2017-11-19T21:51:01+11:00 https://pharmadispatch.com/news/familiar-face-to-lead-hepatitis-australia-board 2017-11-20T17:00:01+11:00 https://pharmadispatch.com/news/uk-recommends-funding-for-new-breast-cancer-therapies 2017-11-20T17:00:01+11:00 https://pharmadispatch.com/news/biosimilar-awareness-grant-will-proceed 2017-11-20T17:00:01+11:00 https://pharmadispatch.com/news/report-urges-single-process-for-co-dependent-technologies 2017-11-21T17:00:01+11:00 https://pharmadispatch.com/news/new-cancer-collaboration-for-walter-and-eliza-hall-institute 2017-11-21T17:00:01+11:00 https://pharmadispatch.com/news/tga-backs-another-priority-review-for-opdivo 2017-11-21T17:00:01+11:00 https://pharmadispatch.com/news/new-doubts-over-timing-of-parliamentary-backing-for-key-reforms 2017-11-21T17:00:01+11:00 https://pharmadispatch.com/news/game-of-chance-secures-ema-for-amsterdam 2017-11-22T17:00:01+11:00 https://pharmadispatch.com/news/sector-must-unite-on-sustainable-funding-for-pbs 2017-11-22T17:00:01+11:00 https://pharmadispatch.com/news/names-changes-for-two-australian-biotechs 2017-11-22T17:00:01+11:00 https://pharmadispatch.com/news/get-the-pbs-policy-discussion-out-of-the-budget-process 2017-11-23T17:00:01+11:00 https://pharmadispatch.com/news/take-off-for-taa-division 2017-11-22T17:00:01+11:00 https://pharmadispatch.com/news/trying-to-prevent-leaks-only-makes-them-more-likely-to-happen 2017-11-23T17:00:01+11:00 https://pharmadispatch.com/news/another-company-goes-direct 2017-11-23T17:00:01+11:00 https://pharmadispatch.com/news/disruption-is-the-future-of-drug-development 2017-11-28T17:00:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics 2017-11-23T17:00:01+11:00 https://pharmadispatch.com/news/new-report-identifies-investment-gap-in-nz 2017-11-24T17:00:01+11:00 https://pharmadispatch.com/news/an-investment-gap-in-australia 2017-11-24T17:00:01+11:00 https://pharmadispatch.com/news/health-costs-are-going-up-and-they-are-not-going-away 2017-11-24T17:00:01+11:00 https://pharmadispatch.com/news/what-could-the-minister-actually-do 2017-11-23T23:53:01+11:00 https://pharmadispatch.com/news/guild-rallies-members-against-companies-going-direct 2017-11-27T17:00:01+11:00 https://pharmadispatch.com/news/an-unworkable-ban-will-not-fix-anything 2017-11-27T17:00:01+11:00 https://pharmadispatch.com/news/get-ready-for-mount-kosciuszko-challenge-2018 2017-11-27T17:00:01+11:00 https://pharmadispatch.com/news/whose-privacy-are-you-protecting 2017-11-27T17:00:01+11:00 https://pharmadispatch.com/news/was-it-just-a-flagging-or-something-more 2017-11-28T17:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-might-be-wondering-what-is-going-on 2017-11-28T17:00:01+11:00 https://pharmadispatch.com/news/potential-delay-disgraceful 2017-11-28T17:00:01+11:00 https://pharmadispatch.com/news/exclusive-biosimilar-a-flagging-saved-companies-from-something-f 2017-11-29T17:00:01+11:00 https://pharmadispatch.com/news/senate-report-wants-tga-pbac-process-change 2017-11-29T17:00:01+11:00 https://pharmadispatch.com/news/government-anticipating-patent-loss-on-key-biologics 2017-11-29T17:00:01+11:00 https://pharmadispatch.com/news/specialists-urge-action-on-treatments-for-liver-cancer 2017-11-29T17:00:01+11:00 https://pharmadispatch.com/news/treatment-free-label-extension-for-novartis-therapy 2017-11-30T17:00:01+11:00 https://pharmadispatch.com/news/uk-moves-ed-drug-over-the-counter 2017-11-30T17:00:01+11:00 https://pharmadispatch.com/news/the-real-challenge-is-getting-behind-the-curtain 2017-11-30T17:00:01+11:00 https://pharmadispatch.com/news/government-must-curate-not-control 2017-11-30T17:00:01+11:00 https://pharmadispatch.com/news/pbs-funding-buckets-would-be-a-disaster 2017-12-01T17:00:01+11:00 https://pharmadispatch.com/news/amazon-could-swamp-direct-distribution-as-an-issue 2017-11-30T23:02:01+11:00 https://pharmadispatch.com/news/asmi-says-role-antihistamines-still-have-a-role 2017-12-01T17:00:01+11:00 https://pharmadispatch.com/news/actinogen-capital-raise-to-fund-xanamem-development 2017-12-01T17:00:01+11:00 https://pharmadispatch.com/news/amazon-in-talks-with-us-drugmakers 2017-12-04T17:00:01+11:00 https://pharmadispatch.com/news/australia-facing-risks-of-us-corporate-tax-cut 2017-12-04T17:00:01+11:00 https://pharmadispatch.com/news/its-all-about-rebates 2017-12-04T17:00:01+11:00 https://pharmadispatch.com/news/rca-welcomes-new-listing 2017-12-04T17:00:01+11:00 https://pharmadispatch.com/news/pbs-more-and-more-just-a-safety-net 2017-12-05T17:00:01+11:00 https://pharmadispatch.com/news/australia-still-in-denial-about-innovation 2017-12-05T17:00:01+11:00 https://pharmadispatch.com/news/racgp-wants-support-to-fight-antibiotic-resistance 2017-12-06T17:00:01+11:00 https://pharmadispatch.com/news/hcv-therapies-may-not-even-be-in-the-top-10 2017-12-05T17:00:01+11:00 https://pharmadispatch.com/news/expectations-and-cso-standards-are-not-the-same-thing 2017-12-05T17:00:01+11:00 https://pharmadispatch.com/news/hunt-thanks-sector-for-support-on-tga-reforms 2017-12-05T17:00:01+11:00 https://pharmadispatch.com/news/what-is-inside-the-cso 2017-12-06T17:00:01+11:00 https://pharmadispatch.com/news/new-formulation-reduces-pill-burden 2017-12-06T17:00:01+11:00 https://pharmadispatch.com/news/csl-secures-rights-to-organ-transplant-rejection-therapy 2017-12-06T17:00:01+11:00 https://pharmadispatch.com/news/government-wants-performance-not-regulation-dhls-resnick 2017-12-06T17:00:01+11:00 https://pharmadispatch.com/news/australian-companies-down-the-list-on-rd-spend 2017-12-07T17:00:01+11:00 https://pharmadispatch.com/news/gsk-disappointed-over-accc-action 2017-12-07T17:00:01+11:00 https://pharmadispatch.com/news/ma-backs-members-against-misleading-claims 2017-12-07T17:00:01+11:00 https://pharmadispatch.com/news/companies-sticking-with-direct-distribution 2017-12-07T17:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-consumer-comments-count 2017-12-08T17:00:01+11:00 https://pharmadispatch.com/news/csl-officially-opens-230m-advanced-manufacturing-facility 2017-12-08T17:00:01+11:00 https://pharmadispatch.com/news/florey-medal-for-gene-therapy-innovator 2017-12-08T17:00:01+11:00 https://pharmadispatch.com/news/leaving-nothing-to-chance-in-bennelong 2017-12-08T17:00:01+11:00 https://pharmadispatch.com/news/ma-distribution-taking-more-of-the-pbs 2017-12-08T17:00:01+11:00 https://pharmadispatch.com/news/merck-welcomes-mavenclad-approval 2017-12-08T17:00:01+11:00 https://pharmadispatch.com/news/time-to-rethink-code-restrictions-carlo-montagner 2017-12-11T17:00:01+11:00 https://pharmadispatch.com/news/new-cancer-medicines-headline-january-pbs-listings 2017-12-11T17:00:01+11:00 https://pharmadispatch.com/news/ato-cautions-on-tax-transparency-report 2017-12-11T17:00:01+11:00 https://pharmadispatch.com/news/patient-group-leader-leaves-lasting-legacy 2017-12-11T17:00:01+11:00 https://pharmadispatch.com/news/short-timeline-for-senate-inquiry 2017-12-11T03:25:01+11:00 https://pharmadispatch.com/news/pbs-the-health-systems-poor-cousin 2017-12-12T17:00:01+11:00 https://pharmadispatch.com/news/labor-seeking-feedback-on-health-platform 2017-12-13T17:00:01+11:00 https://pharmadispatch.com/news/bayer-renews-support-for-heart-of-australia 2017-12-12T17:00:01+11:00 https://pharmadispatch.com/news/csl-secures-new-plasma-agreement 2017-12-12T17:00:01+11:00 https://pharmadispatch.com/news/it-is-the-law-not-the-code-says-ma 2017-12-12T17:00:01+11:00 https://pharmadispatch.com/news/labor-to-fund-prep-until-listed-on-the-pbs 2017-12-12T17:00:01+11:00 https://pharmadispatch.com/news/australia-must-not-fear-innovation-ferris 2017-12-13T17:00:01+11:00 https://pharmadispatch.com/news/just-the-right-time-to-move-on-dr-lynn-weekes 2017-12-13T02:13:01+11:00 https://pharmadispatch.com/news/minister-wants-to-negotiate-an-outcome 2017-12-13T17:00:01+11:00 https://pharmadispatch.com/news/a-lost-decade-for-the-pbs 2017-12-14T17:00:01+11:00 https://pharmadispatch.com/news/new-ceo-for-ebos-group 2017-12-15T05:00:01+11:00 https://pharmadispatch.com/news/former-ceo-returns-as-csl-chair 2017-12-14T17:00:01+11:00 https://pharmadispatch.com/news/asmi-calls-for-a-switch-agenda 2017-12-14T17:00:01+11:00 https://pharmadispatch.com/news/recipients-of-bi-funded-cv-grants-announced 2017-12-15T17:00:01+11:00 https://pharmadispatch.com/news/pfizers-journey-to-the-cbd-begins 2017-12-15T17:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-takes-control-of-promising-loxl2-program 2017-12-15T17:00:01+11:00 https://pharmadispatch.com/news/patients-await-pbac-outcomes 2017-12-15T17:00:01+11:00 https://pharmadispatch.com/news/under-co-payment-market-still-growing 2017-12-15T17:00:01+11:00 https://pharmadispatch.com/news/old-and-new-challenges-for-greg-hunt-in-2018 2017-12-18T17:00:01+11:00 https://pharmadispatch.com/news/inquiry-delivers-interim-report-kind-of 2017-12-18T17:00:01+11:00 https://pharmadispatch.com/news/outcomes-reveal-tough-time-for-many-major-new-therapies 2017-12-18T17:00:01+11:00 https://pharmadispatch.com/news/sector-happy-with-bennelong-result 2017-12-18T17:00:01+11:00 https://pharmadispatch.com/news/government-expected-to-release-budget-update 2017-12-18T17:00:01+11:00 https://pharmadispatch.com/news/one-way-or-another-than-money-is-gone-if-it-ever-really-existed 2017-12-19T17:00:01+11:00 https://pharmadispatch.com/news/ma-calls-for-investment-and-more-reporting-on-supply-chain 2017-12-19T17:00:01+11:00 https://pharmadispatch.com/news/a-second-interim-report-that-looks-exactly-like-the-first-1 2017-12-19T17:00:01+11:00 https://pharmadispatch.com/news/treat-hcv-now-to-eradicate-quickly-and-save 2017-12-19T17:00:01+11:00 https://pharmadispatch.com/news/changes-for-health-in-reshuffle 2017-12-20T01:39:01+11:00 https://pharmadispatch.com/news/increased-investment-our-fundamental-concern-in-2018-wes-cook 2017-12-20T17:00:01+11:00 https://pharmadispatch.com/news/medtronic-officially-opens-new-headquarters 2017-12-20T17:00:01+11:00 https://pharmadispatch.com/news/report-shows-need-for-immediate-action-on-real-time-recording 2017-12-20T17:00:01+11:00 https://pharmadispatch.com/news/spare-a-thought-for-officials-in-reshuffle 2017-12-20T17:00:01+11:00 https://pharmadispatch.com/news/australia-best-in-region-for-prostate-cancer-but-there-is-a-catc 2017-12-20T17:00:01+11:00 https://pharmadispatch.com/news/what-should-be-a-scandal-will-become-a-crisis-without-action 2017-12-22T05:00:01+11:00